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ABSTRACT 
DivIVA is a Gram-positive cell division protein involved in chromosome segregation, 
midcell placement of the cell division machinery, complete septum closure, and polar growth 
and morphogenesis.  Although well conserved across various Gram-positive species, DivIVA is 
believed to be relatively species specific.  One similarity among DivIVA homologues is the 
ability to oligomerize through coiled-coil interaction into complexes comprising 10-12 
monomers.  To date, the importance of DivIVA oligomerization and the N-terminal coiled-coil 
for its proper function in bacterial cell division has not been reported.  This study examined the 
biological significance of DivIVA oligomerization and the N-terminal coiled-coil in bacterial 
cell division. This research provides evidence that the N-terminal coiled-coil and 
oligomerization is essential for the proper biological function of DivIVAEf in E. faecalis cell 
division.  Introduction of point mutations into chromosomal divIVAEf known to disrupt either 
the N-terminal coiled-coil or the two central coiled-coils, involved in oligomerization, were 
found to be lethal unless rescued by in trans expression of wild type DivIVAEf.  Using this 
rescue method, the N-terminal divIVAEf mutant strain, E. faecalis MWMR5, and the mutant 
strain with partial disruption of oligomerization, E. faecalis MWMR10, were successfully 
rescued.  Differential Interference Contrast (DIC) and Transmission Electron Microscopy 
(TEM) were utilized to determine the phenotypes of divIVAEf mutant strains E. faecalis 
MWMR5 and MWMR10.  Both these strains showed asymmetrical division, loss of normal 
lancet shape, and irregular chains.  Full disruption of oligomerization with point mutations in 
both central coiled-coils resulted in a dominant lethal phenotype. These results demonstrate the 
essentiality of the N-terminal coiled-coil and oligomerization of DivIVAEf for its proper 
biological function in E. faecalis cell division. 
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 Previous detection of DivIVA interaction with a novel cell division protein, MLJD1, by 
screening a Yeast Two-Hybrid (Y2H) was weak. GST-pulldown and immunoprecipitation did 
indicate DivIVAEf interaction with MLJD1, but another in vivo assay was required to support 
these results.  In this study I demonstrate a strong interaction, using an in vivo Bacterial Two-
Hybrid (B2H) assay, between DivIVAEf and a fragment of MLJD1 containing two 
cystathionine-beta-synthase (CBS) domains.  The in vitro and in vivo results thus confirm 
interaction between DivIVAEf and MLJD1. 
 Another objective of this study was to determine the localization of DivIVA and 
MLJD1 in E. faecalis.  Localization of DivIVAEf in E. faecalis was found to be similar to 
DivIVA localization in B. subtilis and Streptococcus pneumoniae.  DivIVAEf was diffused 
along the cell membrane and, as chromosome replication and segregation and cell division 
proceeded, DivIVAEf migrated to the cell poles and then concurrently to the division site.  
Intriguingly, MLJD1 was found to localize in the same pattern as DivIVAEf in E. faecalis, 
further implicating MLJD1 as a bacterial cell division protein. 
 Since MLJD1 has potential DNA binding capabilities a proposed model of its role in 
cell division has been proposed.  I hypothesize that MLJD1 could be forming a bridge between 
DivIVAEf and the chromosome to aid in proper chromosomal replication and segregation.  This 
model could explain how DivIVAEf is involved in chromosome replication.  This model is 
similar to the role of RacA in sporulation in B. subtilis where RacA directs the chromosome 
during sporulation through direct interaction with DivIVABs and Spo0J. 
 This study has set some important and essential ground work for developing a novel 
model of cell division for the elusive Gram-positive coccal bacterial strains. 
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1.0 Introduction 
 1.1 Bacterial Cell Division Initiation and Regulation 
  1.1.1 The Bacterial Division and Cell Wall (dcw) Gene Cluster 
 Bacterial cell division has been most extensively studied in the Gram-negative bacillus 
Escherichia coli and the Gram-positive bacillus Bacillus subtilis.  Proteins involved in cell 
division were first described in E. coli as having a filamentous temperature sensitive (Fts) 
phenotype when mutated (Bi & Lutkenhaus, 1991).  Mutations in these Fts proteins caused the 
E. coli cells to become filamentous at the non-permissive temperature (Bi & Lutkenhaus, 
1991).  Fts division proteins and other proteins involved in cell division and cell wall synthesis 
have been located on the E. coli chromosome in what is called the division and cell wall 
synthesis (dcw) cluster (Rothfield & Justice, 1997, Margolin, 2001, Margolin, 2003, Vicente & 
Errington, 1996).  The dcw cluster is highly conserved in bacterial species as found in E. coli, 
B. subtilis, Staphylococcus aureus, Enterococcus faecalis, Streptococcus pyogenes, and 
Streptococcus pneumoniae (Fig 1.1) as well as in Neisseria gonorrhoeae (Francis et al., 2000, 
Real & Henriques, 2006, Fadda et al., 2003, Ramirez-Arcos et al., 2005, Massidda et al., 1998).  
Genes within the dcw cluster, such as ftsZ and ftsA, are highly conserved between Gram-
negative and Gram-positive bacteria (Fig 1.1), but there are some significant differences 
between the two.  The major difference seems to be the organization of the genes within the 
dcw cluster.  As seen in Fig 1.1, the dcw cluster in S. pyogenes and S. pneumoniae are in two or 
three segments, respectively, which are located on separate sections of the chromosomes 
(Massidda et al., 1998).  The involvement of all the known and putative division proteins 
transcribed by these dcw genes is very complex and beyond the scope of this study.  However, 
knowing the function of key cell division proteins is imperative for understanding bacterial cell 
division.   
 2
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1: The division and cell wall (dcw) clusters of Escherichia coli (Ec), Bacillus 
subtilis (Bs), Staphylococcus aureus (Sa), Enterococcus faecalis (Ef), Streptococcus 
pyogenes (Spy), and Streptococcus pneumoniae (Spn).  The arrows point in the direction of 
transcription.  Black arrows indicate genes common to all the dcw clusters shown, while 
identical patterns in different dcw clusters represent functional or structural homologues.  White 
arrows represent open reading frames (ORF) unrelated to the dcw genes.  This figure was 
modified from (Massidda et al., 1998). 
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Studying the genes and corresponding proteins involved with the dcw clusters has given 
researchers an understanding of bacterial cell division initiation and regulation. 
1.1.2 Initiation of Bacterial Cell Division and the Proteins Involved in 
Divisome Formation 
 The most conserved division protein across bacterial species is FtsZ (Margolin, 2000).  
FtsZ is a tubulin homolog which has GTPase activity and self oligomerization capabilities that 
allow it to form a dynamic ring along the inner membrane of bacterial cells before septum 
formation (Bi & Lutkenhaus, 1991, Mukherjee & Lutkenhaus, 1998, Addinall & Holland, 
2002).  The formation of the Z-ring is the vital first step in bacterial cell division initiation and 
is known to form before the replicating chromosome is completely segregated (Bi & 
Lutkenhaus, 1991).  A hierarchy of division proteins, including FtsA, ZipA, FtsK, FtsQ, FtsL, 
FtsW, FtsI, and FtsN in E. coli, are recruited after Z-ring formation is established.  The 
recruitment of these proteins forms a complex known as the divisome or septosome (Margolin, 
2005, Goehring & Beckwith, 2005, Weiss, 2004, Di Lallo et al., 2003).  The divisome works at 
the leading edge of the septum and contracts to divide into two daughter cells (Margolin, 2005, 
Harry, 2001).   
  1.1.3 Regulation of Bacterial Cell Division: The Min System in 
Gram-negative Bacteria Escherichia coli and Neisseria gonorrhoeae  
 The most important aspect of bacterial cell division initiation is placement of the FtsZ-
ring in the center of the cell, the midcell site.  Therefore, midcell site selection is vital for 
proper symmetrical division.  Without regulation mechanisms FtsZ can form a ring and 
constrict anywhere at the cellular membrane forming minicells, which contain no DNA, and 
elongated filaments that eventually end up as unhealthy cells, leading to cell death (Begg & 
Donachie, 1985).  The mechanisms utilized for proper placement of the Z-ring have been 
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extensively studied in the Gram-negative rod Escherichia coli (E. coli).  Escherichia coli 
utilizes the Min (minicell gene cluster) proteins to ensure midcell placement of the Z-ring 
(Harry, 2001).  There are three Min proteins, MinC, MinD, and MinE, which are all transcribed 
from the minB operon (de Boer et al., 1989).  MinC acts as a Z-ring inhibitor by 
depolymerizing FtsZ (Hu et al., 1999, Shiomi & Margolin, 2007).  MinD activates MinC by 
forming a reversible complex with MinC, which anchores MinC to the cell membrane (Fig 1.2) 
(Pichoff & Lutkenhaus, 2001, Hu et al., 1999).  With MinC concentrated at the cell membrane 
Z-ring formation is inhibited at that location (Pichoff & Lutkenhaus, 2001, Hu et al., 1999).  
MinE oscillates from one end of the cell to the other and stimulates the ATPase activity of 
MinD, which causes MinCD to dissociate (Fig 1.2) (Shih et al., 2003, Rothfield et al., 2001).  
Dissociated MinC and MinD oscillate down the concentration gradient to the opposite end of 
the cell where it can form a complex once more (Fig 1.2) (Hu & Lutkenhaus, 2001).  This 
dynamic oscillation results in the concentration of MinCD complex being least at the midcell 
site and highest at the cell poles (Fig 1.2) (Hu & Lutkenhaus, 2001, Ramirez-Arcos et al., 
2001a, Ramirez-Arcos et al., 2001b, Ramirez-Arcos et al., 2004).  This amazing process 
ensures division at the midcell site and prevents division at the cell poles, resulting in 
symmetrical division. 
 The Min system in the coccal shaped Gram-negative bacterium Neisseria gonorrhoeae 
(N. gonorrhoeae) should be more complex due to the lack of an obvious midcell site.  N. 
gonorrhoeae does utilize the Min system to control FtsZ placement (Ramirez-Arcos et al., 
2001b, Ramirez-Arcos et al., 2002, Ramirez-Arcos et al., 2001a, Ramirez-Arcos et al., 2004).  
The Min proteins from N. gonorrhoeae have been shown to also function in Gram-negative 
bacilli (Ramirez-Arcos et al., 2002), suggesting the Min proteins retain their function despite 
cell shape. 
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Figure 1.2: Schematic diagram of the E. coli Min system for midcell site selection. 
A) MinC and MinD form a complex, capable of inhibiting Z-ring formation, at the cell 
membrane at one end of the cell.  Forming a dynamic ring near midcell, MinE oscillates 
towards the MinCD complexes formed.  B) As MinE reaches the other end of the cell it 
dissociates the MinCD complex.  C) Free MinC and MinD oscillate down a concentration 
gradient to the opposite end of the cell where they form a MinCD complex once more.  The 
dynamic oscillation of MinE, MinD and, by association, MinC results in a MinCD free zone at 
the midcell site allowing Z-ring formation and symmetrical division. 
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Although the Min system prevents division at the cell poles, some research suggests 
there is another mechanism involved in defining the midcell site.  This other mechanism for 
midcell site selection in both B. subtilis and E. coli is called nucleoid occlusion (Woldringh et 
al., 1991).  Nucleoid occlusion occurs when replicating and segregating nucleoids prevent Z-
ring formation in the vicinity of higher DNA concentrations (Harry, 2001).  As chromosomal 
segregation nears completion, the chromosomes move apart leaving an area with decreased 
DNA concentration at the midcell where the Z-ring can then form (Wu et al., 1995, Mulder & 
Woldringh, 1989, Den Blaauwen et al., 1999, Marston & Errington, 1999, Sun et al., 1998).  
Nucleoid occlusion thus prevents septum formation and closing before the chromosomes have 
completely segregated.  The mechanism of nucleoid occlusion in B. subtilis involves the Noc 
protein, which non-specifically associates with the segregating chromosomes and prevents 
divisome assembly in the vicinity of the nucleoid (Wu & Errington, 2004).  The nucleoid 
occlusion protein SlmA in E. coli functions in a similar mannar (Bernhardt & de Boer, 2005).  
It is the combination of nucleoid occlusion and the Min system which provides midcell site 
selection for Z-ring formation (Yu & Margolin, 1999, Margolin, 2000). 
1.1.4 Division in the Gram-positive Rod Shaped Bacterium: Bacillus 
subtilis 
 Bacillus subtilis is a Gram-positive bacillus bacterium that also utilizes Min proteins to 
regulate midcell placement of the Z-ring.  Bacillus subtilis contains MinC and MinD 
homologues, but does not possess a MinE homologue.  In 1973 Reeve et al. created mutations 
in the B. subtilis chromosome using nitrosoguanidine mutagenesis (Reeve et al., 1973).  
Mutations which caused misplacement of the division site in B. subtilis were found in the 
divIVA gene that codes for the DivIVABs (B. subtilis DivIVA) protein.  This mutated DivIVABs 
resulted in division close to the cell poles causing the formation of DNA absent minicells 
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(Reeve et al., 1973).  It was not until later on that the topological function of DivIVA was 
found to be similar to MinE (Cha & Stewart, 1997, Edwards & Errington, 1997).  DivIVA and 
MinE share no sequence similarity, but perform the same topological function of midcell site 
selection for symmetrical division (Marston et al., 1998).  There is, however, a difference 
between the mechanisms used by DivIVABs and MinE to perform midcell site selection.  While 
MinE stimulates oscillation of the Min proteins (Fig 1.2), DivIVABs sequesters MinCD to the 
cell poles, thus preventing division at either pole (Fig 1.3) (Marston et al., 1998, Marston & 
Errington, 1999).  In the absence of DivIVABs, MinD was diffused throughout the entire cell 
and localized to the cell poles only in the presence of functional DivIVABs (Marston et al., 
1998).  Without the dynamic oscillation of MinD, a MinCD free zone is created at the midcell 
site by the elongation of dividing B. subtilis cells.  Therefore, MinCD concentrations decrease 
at the midcell to allow Z-ring formation (Fig 1.3) (Edwards & Errington, 1997, Marston & 
Errington, 1999).  After the Z-ring has stabilized and it becomes insensitive to MinCD 
inhibition, DivIVABs is recruited to the division site where it eventually forms the new cell 
poles of the daughter cells (Edwards & Errington, 1997, Perry & Edwards, 2004).  MinD and 
MinC do not directly interact with DivIVABs.  Instead, DivIVABs interacts with a protein named 
MinJ, which was discovered in B. subtilis and was found to interact with MinD as well 
(Bramkamp et al., 2008, Patrick & Kearns, 2008).  Thus, MinJ completes a bridge between 
DivIVABs and the MinCD complex in order to control midcell placement of the cell division 
machinery by preventing division at the cell poles (Patrick & Kearns, 2008, Bramkamp et al., 
2008).    
   
 
 
 8
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.3: Midcell site selection in Bacillus subtilis.  A) DivIVABs sequesters the MinCD 
complex to the cell poles.  B) As the cell elongates a MinCD free zone appears where the Z-
ring and divisome can form.  C) Once the divisome forms it begins to constrict and DivIVABs is 
recruited to the division site.  D) DivIVABs remains at the new cell poles of the daughter cells 
along with MinCD. 
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1.1.5 Gram-positive Coccal Cell Division Mechanisms 
 Gram-positive coccal bacteria such as Enterococcus faecalis, Streptococcus 
pneumoniae, and Staphylococcus aureus are similar to B. subtilis in that they contain DivIVA 
homologues.  They do not, however, contain homologues of any of the three Min proteins 
(Ramirez-Arcos et al., 2005, Pinho & Errington, 2004, Flardh, 2003a).  These round cells lack 
an obvious midcell site and research has not yet illuminated the mechanisms used by these cells 
for proper midcell placement. 
For these reasons, research on the mechanisms used to regulate cell division have 
focused on the function of the division protein DivIVA in B. subtilis and various Gram-positive 
coccal bacteria including E. faecalis (Ramirez-Arcos et al., 2005), S.  pneumoniae (Fadda et al., 
2007), and S. aureus (Pinho & Errington, 2004).  Although most commonly found in Gram-
positive bacterial species, a DivIVA homologue, named FruD, was found in the Gram-negative 
bacterial species Myxococcus xanthus (Akiyama et al., 2003).  Mutations in FruD caused M. 
xanthus cells to become filamentous demonstrating that FruD is required for proper cell 
division (Akiyama et al., 2003).  In the cyanobacterium Synechococcus elongatus there are both 
MinE and DivIVA present in the cells (Miyagishima et al., 2005).  Filimentus cells result from 
disruptions in minE and disruption of divIVA resulted in misplacement and reduced frequency 
of the septum and elongated cells, implying both minE and divIVA play a role in cell division 
(Miyagishima et al., 2005). 
1.2 DivIVA : A Gram-positive Cell Division Protein 
 1.2.1 divIVA Chromosomal Location 
 The focus of bacterial cell division in Gram-positive coccal cells has not only been on 
DivIVA, but also on the protein products of genes in the dcw cluster.  The chromosomal 
localization of divIVA typically appears downstream ftsZ with four to five ORFs of various ylm  
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Figure 1.4:  Region downstream ftsZ in B. subtilis (Bs), Staph. aureus (Sa), Streptococcus 
pneumoniae (Spn), and Streptococcus pyogenes (Spy).  Arrows indicate direction of 
transcription.  The names of genes and size of transcribed proteins are indicates under each 
open reading frame (ORF).  Figure modified from (Massidda et al., 1998). 
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genes in between (Fig 1.4) (Massidda et al., 1998).  The genes ylmE, ylmF, ylmG, and ylmH in 
S. pneumoniae were found to be involved in cell division and/or chromosomal segregation, as 
their disruption resulted in altered cell shape, cells in chains or tetrads, thinner or incomplete 
septum formation, and/or decrease or absent nucleoids (Fadda et al., 2003).  Disrupting divIVA 
in S. pneumoniae has the most detrimental effect on cell growth rates, incomplete septum 
formation, and chromosomal distribution (Fadda et al., 2003).  In bacteria which possess 
DivIVA homologues, divIVA is found on the chromosome immediately upstream the isoleucyl 
tRNA synthetase gene and is considered as part of the dcw cluster (Fig 1.4) (Cha & Stewart, 
1997, Massidda et al., 1998, Ramirez-Arcos et al., 2005, Ramos et al., 2003).  Bioinformatic 
analysis confirmed that divIVA is  part of the Enterococcal dcw cluster, thus implicating 
DivIVA as a cell division protein (Fig 1.5) (Ramirez-Arcos et al., 2005).  In particular, E. 
faecalis divIVA (divIVAEf) is potentially co-transcribed with six up-stream division proteins due 
to the placement of three ρ-independent transcriptional terminators, one immediately 
downstream divIVAEf (Fig 1.5; (Ramirez-Arcos et al., 2005)).  Transcription of divIVA in E. 
faecalis and other Gram-positive bacteria is controlled by a divIVA promoter and its 
transcription is not effected by mutations in genes upstream in the dcw gene cluster (Cha & 
Stewart, 1997, Fadda et al., 2003, Ramirez-Arcos et al., 2005).  divIVAEf transcription may also 
be controlled by the ftsA promoter upstream in the dcw cluster (Ramirez-Arcos et al., 2005). 
1.2.2 Multiple Biological Functions of DivIVA 
 DivIVA is a multifunctional protein, essential in chromosome segregation and cell 
division in E. faecalis (Ramirez-Arcos et al., 2005) as in B. subtilis in which it also plays a role 
in sporulation (Edwards & Errington, 1997, Thomaides et al., 2001, Errington, 2001).   
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Figure 1.5:  Enterococcus faecalis V583 division and cell wall synthesis (dcw) cluster.  The 
gene organization and transcriptional direction running the same way for every gene.  The 
divIVAEf gene is circled in red.  T- putative ρ-independent transcriptional terminator; P- putative 
σ70 promoter (Ramirez-Arcos et al., 2005).  
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In S. pneumoniae, Streptomyces coelicolor, and Brevibacterium lactofermentum DivIVA is also 
essential for polar growth and morphogenesis (Flardh, 2003a, Flardh, 2003b, Fadda et al., 2007, 
Ramos et al., 2003).  Disruption or overexpression of divIVA causes a variety of cell division 
and morphology defects including misplacement of the divisome, incomplete formation of the 
septum, filamentation, and swelling of the cells depending on the host species (Cha & Stewart, 
1997, Ramos et al., 2003, Ramirez-Arcos et al., 2005, Fadda et al., 2007).  Although DivIVA is 
capable of performing similar functions such as those involved in cell division and chromosome 
segregation in B. subtilis, E. faecalis, and S. pneumoniae, the protein does appear to have 
species-specific functions.  Ramirez-Arcos et al. (2005) demonstrated the species specificity of 
DivIVA through the inability of DivIVA from E. faecalis (DivIVAEf) to complement DivIVA 
null mutants of B. subtilis and S. pneumoniae.  The species specificity of DivIVA may imply 
the ability to interact with specific proteins within individual species has evolved and adapted 
in order for DivIVA to carry out its multiple functions within specific species (Ramirez-Arcos 
et al., 2005). 
  1.2.3 Cellular Localization of DivIVA 
 Among the multiple functions of DivIVA there are similar localization patterns among 
Gram-positive species.  DivIVA in Streptococcus pneumoniae (DivIVASp) localized to the cell 
poles and concurrently to the site of cell division (Fadda et al., 2007).  DivIVASp localized to 
the cell division site after FtsZ ring formation had been initiated (Fadda et al., 2007, Edwards et 
al., 2000).  In B. subtilis, a DivIVABs–GFP (green fluorescent protein) fusion protein localized 
to the cell poles and site of cell division (Edwards & Errington, 1997).  DivIVABs also targeted 
the site of cell division in B. subtilis after FtsZ ring formation where it remained at the new 
poles of the daughter cells (Edwards & Errington, 1997).  Furthermore, DivIVABs was still able 
to localize to previous cell division sites in outgrowing B. subtilis spores (Hamoen & Errington, 
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2003, Harry & Lewis, 2003).  This indicated DivIVABs localization to previous and new cell 
division sites was independent.  Expression of divIVABs~gfp heterologously in E. coli 
demonstrated DivIVABs could still target the cell poles and division site in the heterogonous 
host background (Edwards et al., 2000). 
Similarities between DivIVA homologues and a fission yeast division protein Cdc 8p 
lead Edwards and colleagues (2000) to study localization patterns of DivIVABs in 
Schizosaccharomyces pombe, a eukaryotic fission yeast species.  Intriguingly, DivIVABs was 
able to target the growth zones and the division septum of S. pombe indicating the conservation 
of DivIVA target specificity across an extreme evolutionary distance (Edwards et al., 2000).  
However, little is known of the precise mechanism utilized by DivIVA to localize to new and 
nascent division sites.   
 The amazing ability of DivIVA to localize to cell poles (nascent cell division sites) and 
sites of current cell division in homologous, heterologous, and eukaryotic hosts suggests that a 
marker is conserved across bacterial species and eukaryotes (Edwards et al., 2000, Fadda et al., 
2007, Edwards & Errington, 1997).  The marker recognized by DivIVA homologues for 
localization at nascent and new division sites is yet unknown, but the key to the answer may lie 
in the structure of DivIVA and interaction with a hierarchy of division proteins (Edwards et al., 
2000). 
  1.2.4 DivIVA Structure and Complex Formation 
 DivIVA homologues have a significant degree of sequence similarity in their N-terminal 
(Fig 1.6) and in each of B. subtilis, E. faecalis, and S. pneumoniae, DivIVA can self interact to 
form oligomer structures comprised of 10-12 monomers in vitro and in vivo (Rigden et al., 
2008, Fadda et al., 2007, Edwards et al., 2000).  Conservation of the N-terminal and complex 
oligomer formations could mean the N-terminal and oligomer formation are essential for proper  
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Figure 1.6: Multiple sequence alignment (MSA) of DivIVA homologues.  MSA was performed 
using ClustalWand the Jalvieweditor (http://www.ebi.ac.uk/Tools/clustalw, last accession 
September 26, 2007) (Rigden et al., 2008). Twenty-seven sequences were selected from 27 
bacterial species representing 70 divIVA loci annotated in the TIGR database 
(http://cmr.tigr.org/tigr-scripts/CMR/CmrHomePage.cgi, last accession on September 25, 2007). 
The deduced amino acid sequences were obtained from NCBI database 
(http://www.ncbi.nlm.nih.gov/sites/entrez, last accession on September 25, 2007). Shadowed boxes 
indicate residues with an identity of ≥70% across the sequences. Black bars represent the positions 
of predicted coiled-coils of E. faecalis (Ef) DivIVA. Black arrows indicate conserved residue R18 
and G19. Star indicates conserved residue A78, and dashed arrow shows L120 in B. subtilis 
DivIVA and L143 of DivIVAEf.   This figure is from Supplementary Material (Rigden et al., 2008) 
 
Ef: Enterococcus faecalis, V583, AAO80808 
Bs: Bacillus subtilis, CAB06818 
Ba: Bacillus anthracisAmes, AAP2776 
Bce: Bacillus cereus, ATCC10987, NP_980236  
Bcl: Bacillus clausii, KSM-K16, BAD64878 
Bh: Bacillus halodurans, C-125, BAB06265 
Bl: Bacillus licheniformis, ATCC 14580, YP_091349 
Bt: Bacillus thuringiensis konkukian, 97-27, AAT61098 
Cp: Clostridium perfringens, 13, NP_562767 
Ch: Cytophaga hu chinsonii, ATCC33406, YP_677387 
Dv: Desulfovibrio vulgaris Hildenborough, YP_010592 
Gk: Geobacillus kaustophilus, HTA426, BAD75420 
La: Lactobacillus acidophilus, NCFM, P_193709 
Lp: Lactobacillus plantarum, WCFS1, NP_785685 
Lsal: Lactobacillus salivarius, UCC118, YP_535731 
Lsak: Lactobacillus sakei 23K, P_395369 
Li: Listeria innocua CAC97358 
Lm: Listeria monocytogenes CAD00098 
Mx: Myxococcus xanthus DK1622, YP_631315 
Oi: Oceanobacillusi heyensis HTE831, BAC13439 
Sa: Staphylococcus aureus BAB42539 
Sm: Streptococcus mutans UA159, NP_720993 
Spn: Streptococcus pneumoniae AAC95445 
Spy: Streptococcus pyogenes MGAS315, AAM79774 
St: Streptococcus thermophilus CNRZ1066, YP_141148 
Syt: SymbiobacteriumthermophilumIAM 14863, YP_075059 
Tm: Thermoanaerobactertengcongensis, NP_623196. 
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Figure 1.6 continued 
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Figure 1.6 continued 
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functions of DivIVA (Rigden et al., 2008, Fadda et al., 2007, Edwards et al., 2000).  While the 
DivIVA N-terminal is well conserved across DivIVA homologues the C-terminal is much more 
variable (Edwards et al., 2000, Rigden et al., 2008).  Additional bioinformatic analysis has 
shown B. subtilis, S. pneumoniae, and E. faecalis DivIVA to have a high propensity to form 
coiled-coil structures (Edwards et al., 2000, Rigden et al., 2008, Fadda et al., 2007, Rigden, 
2005).   Bacillus subtilis DivIVABs has a short C-terminal and is comprised of two predicted 
coiled-coils, one at the N-terminal and one at the central region (Muchova et al., 2002b, 
Muchova et al., 2002a, Rigden et al., 2008, Rigden, 2005).  A mutation in the central coiled-
coil of DivIVABs from leucine to proline at residue 120 (L120P) reduced oligomer complex 
formation by 50% (Muchova et al., 2002b).  DivIVA from E. faecalis (DivIVAEf), by contrast 
has four predicted coiled-coils, one at the N-terminus, two in the central region, and one at the 
C-terminus (Rigden, 2005). It has recently been determined, by creating point mutations at 
conserved residues, that the central coiled-coils in DivIVAEf are required for oligomerization, 
as these mutations largely reduced oligomer formation (Table 1.1) (Rigden, 2005).  The point 
mutation in E. faecalis DivIVAEf L143P, corresponding to the L120P mutation in B. subtilis 
DivIVABs, was one of the mutations which decreased oligomerization (Table 1.1) (Rigden et 
al., 2008).  Point mutations disrupting the N-terminal and C-terminal coiled-coils of DivIVAEf 
did not result in decreased oligomerization (Table 1.1) (Rigden, 2005). 
1.3 Enterococcus faecalis DivIVAEf Interaction with a Novel Putative Division 
Protein – MLJD1 
  1.3.1 DivIVAEf Interaction with a Novel Putative Division Protein 
A novel, putative division protein was discovered in the Dillon Laboratory by screening 
an E. faecalis DNA library using a Yeast Two-Hybrid (Y2H) assay with DivIVAEf as the bait.  
Tentatively named MLJD1, this novel division protein was shown to interact with DivIVAEf  
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Table 1.1: DivIVAEf mutations and their effects on oligomerization 
 
divIVAEf 
 mutationsa  
 
 
Complex Mass [kDa]/ 
Number of monomersb 
 
 
Point Mutation Locations and their 
effect on DivIVAEf oligomerization 
MR5: E37P, N43P, 
L46D, L50E, L57F 
1003.38 / 37.16 N-terminal point mutations: 
oligomerization conserved 
MR10: L143P 841.1 / 31 Point mutation in second central coiled 
coil: partial disruption of 
oligomerization 
MR15: L104P, I115P, 
I125P 
27 / 1.0 Point mutations in first central coiled-
coil: full disruption of oligomerization 
MR16: L104P, I115P, 
I125P, L143P 
40.4 / 1.5 MR10 and MR15 mutations combined: 
complete disruption of oligomerization 
Wild type divIVAEf 1011.83 / 37.47 Normal oligomerization 
 
a
 The divIVA mutations were created by site directed mutagenesis (Rigden, 2005). E. coli XL-
1Bule and E. coli DH5α were used for cloning purposes. 
 
b Gel-filtration (superose-6) was used to determine the molecular mass in kilodaltons (kDa) 
and determine the number of monomers in each complex (Rigden, 2005). Native gel-
electrophoresis (data not shown) was also used to determine molecular weight (Rigden, 2005). 
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using co-immunoprecipitation, GST-pulldown, and quantitative Y2H assays (Liao et al., 
manuscript in preparation).   
MLJD1 is a 209 amino acid protein with a predicted molecular weight of 23.41 kDa 
(Liao et al., manuscript in preparation).  It has a putative DNA binding helix-turn-helix 
(HTH_11) motif at the N-terminal and two cystathionine-beta-synthase (CBS) domains, one in 
the central region and the second in the C-terminal end (Fig 1.7).  The HTH_11 superfamily of 
winged helix DNA binding proteins is mostly found in bacterial proteins, such as BirA, which 
regulate transcription of the biotin operon in E. coli (Wilson et al., 1992).  E. coli BirA acts as a 
transcription factor and an enzyme capable of catalyzing the reaction involving ATP and biotin 
to produce biotinyl-5’-adenylate (Eisenberg et al., 1982, Eisenberg & Hsiung, 1982).  HTH_11 
DNA binding domains are also found in proteins involved in regulating amino acid 
biosynthesis, such as LysM, and carbohydrate metabolism as with LicR and FryR (Tobisch et 
al., 1999, Reizer et al., 1994).  Sporulation in B. subtilis requires interaction of RacA with DNA 
and DivIVA in an Spo0J/ Soj dependent manner to draw the origin of one chromosome into the 
forespore (Ben-Yehuda et al., 2003).  During sporulation RacA displaces MinCD from being 
sequestered at the cell poles by DivIVABs and is sequestered to the cell poles itself (Ben-
Yehuda et al., 2003).  The MLJD1 equivalent in B. subtilis, YqzB or CcpN, binds to the 
promoter regions of pckA and gapB to repress transcription and subsequently production of 
PckA and GapB, enzymes required for gluconeogenic growth, when grown in the presence of 
preferred carbon sources, like glucose (Servant et al., 2005, Tannler et al., 2008). 
CBS domains are found in many proteins with different functions including: chloride 
channels (Lloyd et al., 1997), inosine-monophosphate dehydrogenase (Sintchak et al., 1996), 
and cystathionine-beta-synthase (Bateman, 1997).  CBS domains typically occur in pairs  
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Figure 1.7:  Diagram of predicted MLJD1 domains.  HTH_11: potential DNA binding 
domain; CBS: cystathionine beta-synthase domain; NH2: N-terminal; COOH: C-terminal. 
Domains determined by bioinformatic analysis with Pfam (http://pfam.sanger.ac.uk/) and an 
Entrez protein blast  
(http://www.ncbi.nlm.nih.gov/sites/gquery).  Both programs were used with default settings.   
Program used to creat image to scale: http://ca.expasy.org/cgi-bin/prosite/mydomains/ 
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forming a stable globular domain called a Bateman domain (Ponting, 1997, Kemp, 2004, 
Bateman, 1997).  Mutations in CBS domains of various human proteins cause genetic disorders 
including homocystinuria, retinitis pigmentosa, and congenital myotonia (Kemp, 2004).  In 
bacteria, CBS domains have been identified in proteins such as ABC transporters and inosine-
5’-monophosphate dehydrogenase (IMPDH), which is involved in GTP synthesis, as well as in 
proteins of unknown function (Biemans-Oldehinkel et al., 2006, Zhang et al., 1999).  CBS 
domains are also capable of binding adenosyl compounds ATP, AMP or S-AdoMet, depending 
on the protein (Kemp, 2004).  The protein similar to MLJD1 in B. subtilis, CcpN (or YqzB) has 
been found to bind ATP and ADP (Licht et al., 2008).  CcpN also has a different secondary 
structure depending on which ligand it is bound to (ATP or ADP) (Licht et al., 2008).  ATP 
along with an acidic environment induce pckA and gapB repression capabilities of CcpN, while 
ADP seems to relieve CcpN of this repression function (Licht et al., 2008). 
1.3.2 Predicted Domains Involved in DivIVAEf Interaction with MLJD1 
Deletional mutations and truncation in DivIVAEf and MLJD1 were used to elucidate 
potential points of interaction between these two proteins.  It was previously determined that a 
fragment of MLJD1, amino acids 78-209 containing the CBS domains (Fig 1.7), interacted with 
the second coiled-coil (amino acids 60-130) of DivIVAEf (Liao et al., manuscript in progress).  
The second coiled-coil of DivIVAEf is also implicated in self interaction, which may elucidate 
the function of MLJD1 in cell division (Rigden et al., 2008, Rigden, 2005). 
 1.3.3 MLJD1 is an Essential Division Protein 
Expression of MLJD1 was confirmed through RT-PCR and was purified for subsequent 
development of rabbit polyclonal antibody to detect MLJD1 in Western-blots (Liao et al., 
manuscript in progress).  The gene encoding MLJD1, mljd1, is conserved in Gram-positive 
bacteria (Liao et al., manuscript in progress).  No MLJD1 homologues have been identified in 
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Gram-negative organisms.  Attempts were made to knockout mljd1 in the E. faecalis 
chromosome by insertion of a kanamycin resistance cassette.  The knockout proved lethal as no 
viable cultures could be obtained.  A marker rescue method, previously developed in the our 
laboratory (Ramirez-Arcos et al., 2005), was used to express wild type MLJD1 in trans.  
Expression of wild type MLJD1 was minimized, as previously done (Ramirez-Arcos et al., 
2005), to determine the MLJD1 knockdown phenotype.  The knockdown resulted in retarded 
growth of the cells, morphological aberrations, and cell death (Liao et al., manuscript in 
progress).  The in trans complementation was also unable to fully restore the cells back to the 
wild type phenotype further confirming the essentiality of MLJD1 (Liao et al., manuscript in 
progress).  
Escherichia coli has previously been identified as a useful model organism to study the 
effects of  divIVAEf overexpression, which resulted in filamentous cells caused by incomplete 
septation and shorter cells caused by division close to the cell poles (Ramirez-Arcos et al., 
2005).  Overexpression of mljd1 in E. coli inhibited cell growth (Liao et al., manuscript in 
progress).  The essentiality of mljd1 in E. faecalis, interaction of MLJD1 with DivIVAEf and its 
effects on E. coli cell division implicate MLJD1 as a putative division protein. 
 1.4 Rational for using Enterococcus faecalis as a Model Organism and Studying  
 DivIVAEf and MLJD1 Cell Division Proteins 
Enterococcus faecalis was chosen as a model organism for studying Gram-positive 
coccal cell division because very little is known about the mechanisms it utilizes for cell 
division.  E. faecalis is an important bacterium in the medical world, as it is known to cause 
nosocomial infections (Clewell, 1981).  Multiple drug resistant bacteria, such as vancomycin 
resistant Enterococci (VRE) (Cetinkaya et al., 2000), also exist and Enterococci may be 
capable of transferring their multiple antibiotic resistances to other bacterial species (Jones et 
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al., 1987).  Vancomycin is a drug of last resort when other antibiotics are ineffective.  A rise in 
resistance to vancomycin could result in incurable bacterial infections.  Also, because of the 
danger of nosocomial infection to hospital patients and this increasing concern of multiple drug 
resistant bacteria, studying cell division in E. faecalis could help develop more effective 
antibiotics, potential vaccines, and/or strategies for controlling drug resistance and nosocomial 
infections. 
 Due to the species specific functions of the Gram-positive cell division protein 
DivIVA, it is useful to study DivIVA in a number of representative Gram-positive species.  
DivIVA from B. subtilis, S. pneumoniae, and E. faecalis are known to contain coiled-coils and 
oligomeriz into complexes of 10-12 monomers (Fadda et al., 2007, Edwards et al., 2000, 
Rigden, 2005, Rigden et al., 2008).  Previous research in our laboratory identified the two 
central coiled-coils of DivIVAEf to be essential for oligomerization (Rigden, 2005).  However, 
the biological significance of DivIVA oligomerization had not yet been determined for any 
DivIVA homologues. 
Understanding DivIVA oligomerization is just part of a greater picutre.  While B. 
subtilis utilizes MinCD to direct midcell placement of the septum, no proteins have yet been 
identified in Gram-positive cocci that direct midcell placement.  Research has shown that 
DivIVA in S. pneumoniae to interact with FtsZ, FtsA, ZapA, FtsK, FtsL, and Spo0J (Fadda et 
al., 2007).  Our laboratory has recently found DivIVAEf to interact with FtsZ, FtsA, DivIB and 
FtsW in E. faecalis (Dillon et al., manuscript in progress).  All of these proteins are involved in 
divisome formation or chromosome segregation.  To develop a novel model for E. faeclalis cell 
division the function of DivIVA should be researched along with how it interacts with other 
division proteins to perform its functions.  Once developed in E. faecalis, the information might 
be applicable to other Gram-positive coccal species. 
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1.5 Hypothesis and Objectives 
 Previous research on E. faecalis DivIVAEf and MLJD1 inspired my thesis work.  
Biochemical experiments identified four coiled-coils in DivIVAEf: one at the N-terminal, two in 
the central region, and one at the C-terminal.  DivIVAEf was also determined to form oligomer 
complexes of 10-12 monomers (Rigden, 2005).  Complex formation was driven by interaction 
of the two central coiled-coils of DivIVAEf (Rigden, 2005).  However, the biological 
significance of DivIVAEf oligomerization in E. faecalis cell division was not determined.  
Interaction between DivIVAEf and MLJD1 had also been determined using in vitro and in vivo 
methods, but required further in vivo experiments to confirm the interaction due to weak 
interaction in the Y2H experiments (Liao et al., manuscript in progress).  Finally, the 
localization patterns of DivIVA and MLJD1 in E. faecalis had not yet been determined and 
potential co-localization of DivIVAEf and MLJD1 could further implicate MLJD1 as a bacterial 
cell division protein. 
My work was motivated by two hypotheses: 
 1) DivIVAEf oligomerization is essential for proper biological function in cell division 
 2)  MLJD1 is a cell division protein in E. faecalis, which interacts with DivIVAEf 
To test these hypothesizes, I established the following objectives: 
1. Introduce various point mutations into chromosomal divIVAEf known to disrupt 
oligomerization and analyze the biological effects by Differential Interference Contrast 
(DIC) Microscopy and Transmission Electron Microscopy (TEM). 
2. Confirm DivIVAEf/MLJD1 interaction and identify specific domains involved in that 
interaction using a Bacterial Two-Hybrid (B2H) system. 
3. Determine the localization of DivIVAEf and MLJD1 in Enterococcus faecalis using 
immunofluorescence microscopy. 
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2.0 Materials and Methods 
 2.1 Bacterial Strains and Growth Conditions 
 Bacterial strains and plasmids used in this study are listed in Table 2.1.  Escherichia coli 
XL1-Blue was used as a host strain for cloning experiments and E. coli R721 as a reporter 
strain for Bacterial Two-Hybrid (B2H) protein interaction studies.  Enterococcus faecalis JH2-2 
was used for immunofluorescence microscopy and for creation of E. faecalis CBWT and the 
divIVA mutant strains E. faecalis MWMR5 and MWMR10.  Escherichia coli XL1-Blue strain 
was grown at 37 oC in Luria-Bertani (LB) medium (Difco, Detroit, MI) supplemented with 100 
μg/ml ampicillin (Amp) and/or 50 μg/ml kanamycin (Kan).  Escherichia coli R721 was grown 
in LB broth (Difco) supplemented with 50 μg/ml Amp and/or 30 μg/ml Kan at 34 oC with 
shaking at 200 rpm.  Enterococcus faecalis strains were grown in Brain Heart Infusion (BHI) 
medium (Difco) supplemented with 125 μg/ml erythromycin (Ery), 500 μg/ml Kan, or 1000 
μg/ml Kan, as required.   
 All bacterial strains were stored in cryogenic tubes in BHI broth (Difco) supplemented 
with 20% glycerol in a -80 oC freezer (Revco). 
 2.2 Plasmid Construction 
  2.2.1 General Polymerase Chain Reaction Amplification Conditions 
 Primers used in this study are listed in Table 2.2.  All primers were designed based on 
the E. faecalis V583 NC_004668 genome available on the NCBI Entrez website 
(http://www.ncbi.nlm.nih.gov/sites/gquery) and produced by Invitrogen (Carlsbad, CA).  
Primers used for cloning experiments were designed to incorporate appropriate digestion sites, 
as indicated in Table 2.2.  
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Table 2.1: Bacterial strains used in this study 
Strains Relevant Genotype Source 
E. coli XL1-Blue hsdR17, supE44, recA1, endA1, gyrA46, thi 
relA1, lac/F’ [proAB+, lacIq, 
lacZDM15::Tn10(Tetr)] 
Stratagene 
E. coli R721 71/18 glpT :: O-P434/P22 lacZ (Di Lallo et al., 2001) 
E. faecalis JH2-2 wild type, RifR, FusR ATCC 29212 (Jacob 
& Hobbs, 1974) 
E. faecalis JH2-2+R JH2-2 carrying  pMSPSRDiv-2 
(PdivIVA-divIVAEf) 
(Ramirez-Arcos et al., 
2005) 
E. faecalis CBWT KanR this study 
E. faecalis MWMR5 JH2-2 divIVAEf mutations (E37P, 
N43P, L46D, L50E, L57F) carrying 
pMSPSRDiv-2 (PdivIVA- divIVAEf); 
kanR EryR 
this study 
E. faecalis MWMR10 JH2-2 divIVAEf  point mutation 
(L143P) carrying pMSPSRDiv-2 
(PdivIVA- divIVAEf); kanR EryR 
this study 
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Table 2.2: Oligonucleotide primers used in this study 
 
Primer Sequence (5’- 3’)1 Restriction 
Endonucleae 
Site 
Product 
CBdivIVA-
F 
GCGTCGACTATGGCATTAAC SalI divIVAEf 
CBdivIVA-
R 
GCGGATCCCTATTTTGATTC2 BamHI divIVAEf 
CBmljd1-F GCGTCGACGATGAAATTAAG SalI mljd1 
CBmljd1-R GCGGATCCTTATCTGTTTTG2 BamHI mljd1 
CBS1-F GCGTCGACGGAGATCATGAGTCCAC
CA 
SalI sequence coding 
for CBS1 or 
CBS1CBS2 
domains of mljd1 
CBS2-R GCGGATCCCTACGTAATATAGGTTAA
AATTTTCGT2 
BamHI sequence coding 
for CBS2 or 
CBS1CBS2 
domains of mljd1 
CBkan-up GCGCTCTAGAGTGGTTTCAAAATCGG
CTCCG 
XbaI PaphA-3 ~ aphA-3 
CBkan-
down 
GCGCGTCGACTAGGTACTAAAACAA
ATCATC2 
SalI PaphA-3 ~ aphA-3 
AFdiv-up GCGCGTCGACATAGACAGAACGTTT
AATGTTTATT 
SalI 500 base pair 
sequence after 
divIVAEf 
AFdiv-
down 
GCGCCTGCAGGAATATTTCCGTTTGC
ATACGG2 
PstI 500 base pair 
sequence after 
divIVAEf 
IVA-5 GCGCGGATCCATGGCATTAACTCCAT
TAGA 
BamHI divIVAEf 
CBIVA-2 GAGATCTAGACTATTTTGATTCTTCTT
CAA2 
XbaI divIVAEf 
CH-F TTCATTCAGACGAAGTTGTG N/A divIVAEf  and 117 
bp upstream 
divIVAEf
CH-R GAACTGCATCTAGGATAGTG2 N/A divIVAEf and 102 
bp downstream 
divIVAEf
1Restriction endonuclease sites are underlined 
2Anneals to complementary strand 
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PCR reactions were carried out in a Perkin-Elmer Gene Amp 9600 Thermocycler (Perkin 
Elmer, Wellesly, MA) as follows: 5 min at 94 oC; 35 amplification cycles comprising 
denaturation at 94oC for 15 seconds, annealing at temperature appropriate to primer for 15 
seconds (sec), and extension at 72 oC for 45 sec to one min depending on sequence length.  For 
the final extension, after completion of cycles, samples were incubated at 72 oC for 10 min and 
held at 4 oC until samples were removed from the thermocycler.  PCR products were purified 
with a PCR Purification Kit (Qiagen Mississauga, ON) before being used for DNA sequencing 
and/or cloning. 
2.2.2 Cloning for Bacterial Two-Hybrid to Study Protein-Protein 
Interactions 
The self-interaction of DivIVAEf and interaction between DivIVAEf and MLJD1, 
DivIVAEf and the fragment of MLJD1 incorporating the CBS domains, and between DivIVAEf 
containing point mutation L104P, I115P, I125P, and L143P (collectively named MR16) and the 
MLJD1 CBS domain fragment were studied using a Bacterial Two-Hybrid (B2H) system 
(described in Appendix A).  To perform the B2H assay, the genes of the proteins under study, 
divIVAEf (wild type and mutant), mljd1, and the mljd1 fragment which comprises the sequence 
encoding the CBS domains (a.a. 79-199), had to be cloned into the expression vectors designed 
for the B2H system (pcI434 and pcIP22; see Table 2.3) (Di Lallo et al., 2001).  The vectors sent 
by Di Lallo et al. (2001) were p434ftsZ and p22minC (pcI434 and pcIP22 with ftsZ and minC 
cloned in; Table 2.3).  I was not interested in studying FtsZ or MinC, so the ftsZ and minC were 
digested out of the plasmids p434ftsZ and p22minC, respectively.   
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Table 2.3: Plasmids used in this study 
Plasmid Relevant Genotype Source 
p434ftsZ pcI434 derivative carrying ftsZ (Di Lallo et al., 2001) 
p22minC pcIP22 derivative carrying minC (Di Lallo et al., 2001) 
linear pcI434 pACYC177 derivative carrying N-
terminal end of phage 434 repressor 
This study 
linear pcIP22 pACYC177 derivative carrying N-
terminal end of phage P22 repressor 
This study 
pMR16 KanR PT7::divIVAEf (L104P, I115P, 
I125P, L143P) – 6xHis 
(Rigden et al., 2008) 
pdivIVA434 p434minE derivative with minE 
replaced with wt divIVAEf
This study 
pdivIVA22 p22minE derivative with minE 
replaced with wt divIVAEf 
This study 
pcI434~linker pcI434 derivative carrying an extra 
linker 
GeneArt 
pcIP22~linker pcIP22 derivative carrying an extra 
linker 
GeneArt 
p434L-mljd1 pcI434~linker derivative carrying 
mljd1 
This study 
p22L-mljd1 pcIP22~linker derivative carrying 
mljd1 
This study 
p434L-CBS1CBS2 pcI434~linker derivative carrying 
mljd1 sequence that encodes a.a. 79-
199 of MLJD1 containing CBS 
domains 
This study 
p22L-CBS1CBS2 pcIP22~linker derivative carrying 
mljd1 sequence that encodes a.a. 79-
199 of MLJD1 containing CBS 
domains 
This study 
p434L-MR16 pcI434~linker derivative carrying 
mutant divIVAEf (L104P, I115P, 
I125P, L143P) 
This study 
p22L-MR16 pcIP22~linker derivative carrying 
mutant divIVAEf (L104P, I115P, 
I125P, L143P) 
This study 
p3ERM EryR Plac::lacZ (Callegan et al., 1999) 
pTCV-lac EryR KanR::lacZ (Poyart & Trieu-Cuot, 
1997) 
p3ERM-kan KanR p3ERM::PaphA::aphA-3 This study 
p3ERM-kan500 p3ERM-kan::500bp sequence 
immediately downstream divIVAEf
This study 
pMR5 KanR PT7::divIVAEf (E37P, M43P, 
L46D, L50D, L57F) – 6xHis 
(Rigden et al., 2008) 
pMR10 KanR PT7::divIVAEf (L143P) – 6xHis (Rigden et al., 2008) 
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pMR15 KanR PT7::divIVAEf (L104P, I115P, 
I125P) – 6xHis 
(Rigden et al., 2008) 
pCBWT p3ERM-kan500:: wild type divIVAEf This study 
pMWMR5 p3ERM-kan500::divIVAEf (E37P, 
M43P, L46D, L50D, L57F) 
This study 
pMWMR10 p3ERM-kan500::divIVAEf (L143P) This study 
pCBMR15 p3ERM-kan500:: divIVAEf (L104P, 
I115P, I125P) 
This study 
pCBMR16 p3ERM-kan500:: divIVAEf (L104P, 
I115P, I125P, L143P) 
This study 
pMSPSRDiv-2 EryR PnisA PdivIVAEf-divIVAEf (Ramirez-Arcos et al., 
2005) 
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To do so, p434ftsZ and p22minC were double digested with SalI and BamHI (all restriction 
endoneucleases were purchased from MBI Fermentas Burlington, ON) as follows: 10 u (units) 
of BamHI, 20 u of SalI, 4 μl of plasmid DNA, 2 μl of 10x BamHI special buffer (MBI 
Fermentas), and 11 μl of ddH2O.  Manufacturer’s recommendations described SalI as only 50% 
active in BamHI Special buffer, so the units (u) of SalI added to the reaction was doubled (MBI 
Fermenta).  The samples were run on a 1% agarose gel containing 0.2 mg/ml ethidium bromide 
(EtBr) at 100 V for 1 hr in TAE buffer (40 mM Tris base, 0.1% acetic acid, 1 mM EDTA).  The 
band in the gel comprising linear plasmid DNA, linear pcI434 and pcIP22 (Table 2.3), was 
isolated by gel extracted using a Gel Extraction Kit (Qiagen Mississauga, ON).  The bands 
comprising the ftsZ and minC genes, now digested out of the plasmid, were discarded with the 
remaining gel.   
In the next step, divIVAEf was PCR amplified using E. faecalis JH2-2 genomic DNA and 
primers CBdivIVA-F and CBdivIVA-R with an annealing temperature of 53 oC and extension 
time of 1 min.  The primers incorporated 5’ SalI and 3’ BamHI restriction sites.  divIVAEf was 
digested with SalI and BamHI using 20 u of SalI, 10 u of BamHI, 8 μl of insert (divIVAEf), 2 μl 
of BamHI special buffer, and 7 μl of ddH2O.  divIVAEf was cloned into the previously gel 
extracted linear pcI434 and pcIP22 using the following ligation reaction: 3 u of T4 DNA ligase 
(MBI Fermentas Burlington, ON), 3 μl of ATP, 10 μl of insert DNA (divIVAEf), 2 μl of linear 
vector DNA (pcI434 or pcIP22), 2μl of 10x T4 DNA ligase buffer (MBI Fermentas), and 3 μl of 
ddH2O with incubated at room temperature for 2 hr.  Amounts of insert and vector DNA used 
in the ligation reaction varied depending on their concentration. 
Competent E. coli XL1-Blue (Table 2.1) cells were prepared by treatment of log phase 
culture with sterile 0.1 M CaCl2 (Sambrook, 2001).  Competent cells were stored in 0.1 M 
CaCl2 with 17.5% glycerol at -80 oC. The divIVAEf / plasmid ligation reaction, discussed above, 
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was transformed into E. coli XL1-Blue competent cells as follows: 100 μl aliquot of competent 
cells and the divIVAEf ligation reaction was incubated on ice for 30 min and 10 μl of the ligation 
reaction was added to the E. coli XL1-Blue cells.  After incubating on ice for 30 more min, the 
cells were then incubated at 42 oC for 45 sec and once again on ice for 2 min.  Nine hundred μl 
of LB broth was added and the cells were incubated at 37 oC with shaking at 200 rpm for 2-3 
hr. After incubation, cells were collected by centrifuging for 5 min at 5000 rpm in a bench top 
Microfuge 18 Centrifuge (Beckman Coulter, Mississauga, ON) and resuspended in 200 μl of 
LB broth.  Transformed cells were grown on LB agar supplemented with either 50 μg/ml 
Kanamycin (Kan50) or 100 μg/ml Ampacylin (Amp100).  Screening for positive colonies was 
performed using a cracking method as follows: after streaking out isolated colonies and o/n 
incubation, cells from each colony were resuspended in 25 μl of ddH2O and 25 μl of - 9 parts 
cracking buffer (11 mM EDTA, pH 8.0, 11% glycerol, 38.5 mM bromophenol blue) with 1 part 
1 M NaOH.  After incubation at room temperature for 15 min cells were spun for 10 min at 12, 
000 rpm and 25 μl loaded onto a 1% agarose gel and run as previously mentioned.  DNA 
samples run by agarose gel electrophoresis were visualized with a MultiImage Light Cabinet 
(Alpha Innotech Corporation, San Leandro, CA) using the Alpha Imager v5.5 software.  All 
plasmid constructs were isolated and purified (Qiagen Miniprep Kit) and sent to the Plant 
Biotechnology Institute (PBI Saskatoon, SK) for sequencing as described in Section 2.2.4.  
Plasmid resulting from the divIVAEf insertion into linear pcI434 and pcIP22 were named 
pdivIVA434 and pdivIVA22, respectively (Table 2.3). 
Attempts were made to clone mljd1 into the linear pcI434 and pcIP22, but this was 
unsuccessful.  Initial cloning of divIVAEf and mljd1 into the B2H plasmids was difficult because 
ftsZ and minC genes had to be digested out of the plasmids to produce the linear pcI434 and 
pcIP22, so divIVAEf and mljd1 could be cloned.  The digestion and gel extraction of the vector 
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DNA resulted in low concentrations of linear pcI434 and pcIP22, decreasing the efficiency of the 
cloning of divIVAEf and mljd1 into the vectors. Insertion of divIVAEf into linear pcI434 and pcIP22 
was successful, but attempts for cloning in mljd1 failed.  To resolve this cloning issue, plasmids 
p434ftsZ and p22minC were sent to GeneArt (BioPark, Germany) who removed ftsZ and minC 
from the vectors, added a linker (highlighted in Fig 2.1) to incorporate additional digestion 
sites, and re-circularized the plasmids to create pcI434~linker and pcIP22~linker (Fig 2.1).  With 
pcI434~linker and pcIP22~linker there was no need to digest out any unwanted genes (i.e. ftsZ 
and minC) or perform gel extraction.  Plasmids pcI434~linker and pcIP22~linker could be 
digested with SalI and BamHI, as previously described, purified using a PCR purification kit 
(Qiagen), and directly used in ligations.  This resulted in a higher concentration of linear 
pcI434~linker and pcIP22~linker, which greatly improved the efficiency of cloning as described 
below. 
Enterococcus faecalis JH2-2 genomic DNA was used as a template to PCR amplify 
mljd1 using primers CBmljd1-F and CBmljd1-R (Table 2.2) with an annealing temperature of 
53 oC and extension time of 45 sec.  These primers incorporated the same 5’ SalI and 3’ BamHI 
digestion site as the primers used to amplify divIVAEf.  Digested, with SalI and BamHI, mljd1 
was cloned into similar treated pcI434~linker and pcIP22~linker using the ligation reaction 
described for the pdivIVA434 and pdivIVA22 constructs.  The ligation reactions were 
transformed into E. coli XL1-Blue and colonies were screened for plasmid as performed 
previously.   The resulting plasmids were named p434L-mljd1 and p22L-mljd1.  The 434 and 
22 number indicates which phage repressor N-terminal gene sequence is in the plasmid 
(discussed in Appendix A) and the “L” indicates the B2H plasmids with the linker were used 
for cloning (pcI434~Linker and pcIP22~Linker). 
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A.  
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Figure 2.1: Modified Bacterial Two-Hybrid vectors. A) pcI434~Linker and B) pcIP22~Linker 
from Gene Art added a linker (sequence in bold) containing extra digestion sites for cloning 
purposes. 
 
5’- TT AGC ATG GTT AGA GCT GGT TCG TGG TAT GAA GCT TGT GAA CCC TAC GAT ATC AAG TCG ACT TGG AAT 
Ser   Met   Val  Arg Ala   Gly Ser   Trp Tyr   Glu Ala   Cys Glu Pro  Tyr   Asp   Ile    Lys   Ser   Thr Trp Asn
TCA ATA GAT CTG GAC ATA TGG TTC TCG AGT TAC TGC AGA ATC CCG GGT ATG GAT CCT CCG GCG TTC AGC
Ser   Ile    Asp   Leu Asp    Ile    Trp Phe Ser   Ser Tyr   Cys Arg Ile     Pro   Gly Met   Asp  Pro    Pro Ala   Phe Ser
CTG TGC CAC AGC CGA CAG GAT GGT GAC CAC CA -3’
Leu Cys His   Ser   Arg Gln Asp   Gly Asp   His 
SalI
BgI II BamHI
pcI434-Linker
3680bp
Unique MCS
Unique Multiple Cloning Site (MCS) Sequence
pcIP22-Linker
3603bp
a-pep
Unique MCS
5’- A  TTG ATT AGC ATG GTT AGA GCT GGT TCG TGG TCG ACT TGG AAT TCA ATA GAT CTG GAC ATA TGG
Leu IIe Ser  Met   Val    Arg Ala    Gly Ser  Trp Ser   Thr Trp Asn Ser   Ile    Asp  Leu Asp   Ile    Trp
TTC TCG AGT TAC TGC AGA ATC CCG GGT ATG GAT CCC CGG GAA TTC ACT GGC CGT CGT TTT ACA  A -3’
Phe Ser Ser Tyr   Cys Arg Ile     Pro   Gly Met   Asp   Pro  Arg Glu Phe Thr Gly Arg Arg Phe Thr
SalI BgI II
XhoI PstI SmaI BamHI
Unique Multiple Cloning Site (MCS) Sequence
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A gene fragment of mljd1 incorporating the two CBS domains MLJD1 (encoding amino 
acids 79-199) were PCR amplified from E. faecalis JH2-2 using primers CBS1-F and CBS2-R 
with an annealing temperature of 53 oC and an extension time of 45 sec.  The fragment was 
purified, digested with SalI and BamHI, cloned into pcI434~linker and pcIP22~linker, and 
screened for as performed for mljd1.  The resulting plasmids were named p434L-CBS1CBS2 
and p22L-CBS1CBS2 (Table 2.3). 
divIVAEf MR16L104P, I115P, I125P, L143P, which completely disrupts DivIVAEf 
oligomerization (Rigden, 2005), were PCR amplified from pMR16 using primers CBdivIVA-F 
and CBdivIVA-R as performed for wild type divIVAEf.  The PCR fragment was cloned into 
pcI434~linker and pcIP22~linker as performed for mljd1.  The resulting plasmids were named 
p434L-MR16 and p22L-MR16.  MR16 indicates divIVAEf containing the L104P, I115P, I125P, 
and L143P point mutations. 
2.2.3 Cloning Enterococcus Suicide Plasmid to Create Point Mutations in 
divIVAEf on the Enterococcus faecalis Chromosome 
To test the hypothesis that the N-terminal coiled-coil region and oligomerization of 
DivIVAEf are required for its proper biological function in cell division, key point mutations 
disrupting the N-terminal coiled-coil and oligomerization were introduced into divIVAEf on the 
E. faecalis chromosome.  A common method used to introduce mutations into chromosomal 
genes is to use a suicide plasmid such as p3ERM (Table 2.3).  To achieve point mutations in 
chromosomal divIVAEf, the p3ERM constructs required divIVAEf, carrying point mutations 
MR5E37P, M43P, L46D, L50D, L57F, MR10L143P, MR15L104P, I115P, I125P, or MR16L104P, I115P, I125P, I143P 
(Table 1.1) and a 500 bp sequence of homology with the E. faecalis chromosome immediately 
downstream divIVAEf to facilitate homologous recombination.  For screening purposes, a 
kanamycin cassette was also required in the p3ERM constructs.     
 37
To clone the kanamycin cassette into p3ERM, the kan cassette was first PCR amplified from 
pTCV-lac (Table 2.3) using primers CBkan-up and CBkan-down (Table 2.2) with an annealing 
temperature of 54 oC and 1.5 min extension.  The primers incorporated 5’ XbaI and 3’ SalI 
restriction digestion sites.  The PCR product was purified and digested with XbaI and SalI as in 
section 2.2.2, but with 10x Tango buffer (2x) to optimize for these different enzymes.  Plasmid 
p3ERM (Table 2.3) was isolated (Qiagen Miniprep Kit) and digested with XbaI and SalI.  The 
digested Kan cassette and p3ERM (vector) were ligated as mentioned in section 2.2.2.  The 
ligation reaction of the kan cassette with p3ERM was transformed into competent E. coli XL1-
Blue as in section 2.2.2.  Cells were then plated on LB agar supplemented with 125 μl/ml Ery 
(Ery125) plus 50 μl/ml Kan (Kan50) and incubated over night (o/n) at 37 oC.  Between 16-32 
colonies were re-grown on a fresh LB plate containing Ery125 Kan50 for screening using the 
cracking method previously described in section 2.2.2 (Fig 2.2 A).  Recombined plasmids 
suspected of containing the kan cassette were isolated and the kan cassette was amplified using 
the CBkan-up and CBkan-down primers (Table 2.2) to confirm the presence of the cassette.  
The resulting amplification confirmed insertion of the kan cassette into p3ERM with a band at 
approximately 1000 bp (Fig 2.2 B).  The p3ERM plasmid with the kan cassette insert was 
named p3ERM-kan (Fig 2.3 B; Table 2.3).  The next step in the creation of suicide vector 
p3ERM-kan500 (Fig 2.3 C) was to insert the 500 bp sequence, sequence from immediately 
downstream of chromosomal divIVAEf, to the 3’ end of the kan cassette insert in p3ERM-kan.  
The 500 bp sequence was PCR amplified from E. faecalis JH2-2 genomic DNA using primers 
AFdiv-up and AFdiv-down with an annealing temperature of 57 oC (Table 2.2). 
The primers introduced 5’ SalI and 3’ PstI restriction digestion sites onto the 500 bp 
sequence. Using p3ERM-kan as vector, restriction digestion, ligation, and transformation 
procedures were performed as described in section 2.2.2.  
 38
 
A.                                                                              B. 
 
 
 
 
 
 
 
 
 
Figure 2.2: Gel electrophoresis of screening for p3ERM-kan plasmid construct. A) 
Cracking results of p3ERM-kan plasmid constructs.  Cell extracts from three colonies, lanes 2, 
3, and 4, showed plasmids potentially carrying the kan cassette insert.  Lane 5 is cell extract 
showing p3ERM.  B) Plasmids isolated from cell samples from lanes 2, 3, and 4 were 
confirmed to contain the kan cassette through using the plasmids as templates to PCR amplify 
the kan-cassette (lanes 7, 8, and 9 respectively).  DNA ladders are from Invitrogen. 
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Figure 2.3:  Maps of plasmids constructed for creating Enterococcus faecalis divIVAEf 
mutant strains.  A) p3ERM- an Enterococcus suicide vector (Callegan et al., 1999).  B) 
p3ERM with the kanamycin cassette cloned into the XbaI/ SalI digestion site.  C) A 500 bp 
DNA sequence homologous to the DNA sequence immediately downstream divIVAEf on the E. 
faecalis chromosome.  This sequence was cloned into p3ERM-kan to facilitate homologous 
recombination of cloned divIVAEf with divIVAEf on the E. faecalis JH2-2 chromosome.  D) The 
suicide vector pCBWT includes divIVAEf~kan cassette~500 bp of homology.  Mutant divIVAEf 
could be cloned in place of wild type divIVAEf using p3ERM-kan500 as the vector.   
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To screen for potential positive colonies cracking was utilized as for p3ERM-kan (Fig 2.4 A).   
The plasmid p3ERM-kan potentially carrying the 500 bp sequence was used as template for 
PCR using AFdiv-up and AFdiv-down to check for the 500 bp insert (Fig 2.4 B).  The resulting 
plasmid was named p3ERM-kan500 (Fig 2.3 C; Table 2.3). 
The p3ERM-kan500 vector was then used to clone wild type divIVAEf or divIVAEf 
containing MR5E37P, M43P, L46D, L50D, L57F, MR10L143P, MR15L104P, I115P, I125P, or MR16L104P, I115P, 
I125P, L143P point mutations (Table 1.1) upstream of the kan cassette.  Wild type divIVAEf and 
mutant divIVAEf were PCR amplified using primers IVA-5 and CBIVA-2 at an annealing 
temperature of 50 oC (Table 2.2).  The template for the PCR amplification of wild type divIVAEf 
was E. faecalis JH2-2 genomic DNA.  The templates for divIVAEf with mutations MR5E37P, M43P, 
L46D, L50D, L57F was pMR5, point mutation MR10 (L143P) was pMR10, point mutations 
MR15L104P, I115P, I125P was pMR15, and for point mutations MR16L104P, I115P, I125P, L143P was 
pMR16 (Table 2.3).  Digestion sites introduced were 5’ BamHI and 3’ XbaI which were 
utilized to clone divIVAEf into the p3ERM-kan500 vector.  Digestion of p3ERM-kan500 and the 
dvIVAEf PCR product with BamHI and XbaI and subsequent ligation would result in a construct 
comprising divIVA~kan cassette~500 bp of homology cloned into the p3ERM suicide vector 
(Fig 2.5 A).  Cracking was utilized for screening and positive colonies were used to isolate the 
cloned vectors.  The vector containing wild type divIVAEf was named pCBWT (Fig 2.3 D; 
Table 2.3), whereas pMWMR5 contains divIVAEf point mutation construct MR5E37P, M43P, L46D, 
L50D, L57F, pMWMR10 contains point mutation construct MR10L143P, pCBMR15 contains 
MR15L104P, I115P, I125P, and pCBMR16 contains MR16L104P, I115P, I125P, L143P  (Table 2.3).  All 
plasmids were sequenced using primers IVA-5 and CBIVA-2 to check for divIVAEf gene 
integrity and conservation of the desired point mutations. 
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Figure 2.4: Gel electrophoresis of screening for p3ERM-kan500 plasmid construct: A) 
Cracking results of screening for colonies positive for p3ERM-kan500.  Plasmids in Lanes 2, 4, 
and 5 were suspected to have the 500 bp insert while Lane 3 was suspected to contain p3ERM-
kan without the 500 bp insert.  B) PCR amplification of the 500 bp insert, using isolated 
plasmids from sample in lane 2, 4 and 5 as template, confirmed the presence of the 500 bp 
insert in all three isolates. 
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Figure 2.5: Diagram of allelic replacement of chromosomal wild type divIVAEf with 
plasmid divIVAEf carrying various point mutations. How the suicide vectors pCBWT (no 
point mutations in divIVAEf), pMWMR5 (divIVA with point mutations E37P, N43P, L46D, 
L50E, L57F), pMWMR10 (divIVA with point mutation L143P), pCBMR15 (divIVA with point 
mutations L104P, I115P, I125P) or pCBMR16 (divIVA with point mutations L104P, I115P, 
I125P, L143P) was used to replace chromosomal wild type divIVAEf with divIVAEf carrying the 
indicated point mutations.  A) divIVA cloned into p3ERM-kan500; where the sequence of 
homology assists in homologous recombination between B) the divIVAEf and 500 bp sequence 
of homology in the vector and the same sequence in the E. faecalis JH2-2 chromosome.  C) The 
result is allelic replacement in the E. faecalis chromosome of wild type divIVAEf with the 
mutated divIVAEf and insertion of the kanamycin cassette. 
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Once constructed, the modified p3ERM was transformed into E. faecalis JH2-2 (Table 
2.1) to allow allele exchange to occur between divIVAEf in the chromosome and mutated 
divIVAEf, from the vector (Fig 2.5 C). 
2.2.4 Sequencing of Plasmid Constructs and PCR Products 
 The DNA sequence of all genes, cloned into plasmid constructs (the entire gene) and 
their respective PCR products, were obtained at the Plant Biotechnology Institute (PBI 
Saskatoon, SK) to check gene integrity.  Forward and reverse sequences were analyzed using 
an NCBI web page program BLAST 2 Sequences 
(http://blast.ncbi.nlm.nih.gov/bl2seq/wblast2.cgi) to align the sequencing data with the wild 
type sequence on default settings.  All DNA sequence chromatographs were also manually 
analyzed to check any miss matched bases. 
2.3 Creation of Enterococcus faecalis divIVA Mutants 
  2.3.1 Creation of Electrocompetent Enterococcus faecalis Cells 
 To create E. faecalis divIVA mutants, E. faecalis JH-2-2 (Table 2.1) cells were made 
electrocompetent.  Using the protocol of Shepard et al. (Shepard & Gilmore, 1995), E. faecalis 
JH2-2 was grown in M17 broth (Difco) overnight at 37 oC without shaking.  One ml of the 
overnight culture was added to 100 ml of fresh sterile M17 broth (Difco) supplemented with 0.5 
M sucrose and 4% glycine (SGM17 broth) at pH 6.8-7.0 (Shepard & Gilmore, 1995).  Initially 
SGM17 broth containing 2%, 4%, or 8% glycine was tested.  Growth in glycine weakens the 
Gram-positive cell wall allowing entrance of plasmid DNA upon exposure to an electric pulse 
(Shepard & Gilmore, 1995).  A higher percentage of glycine increases the transformation 
efficiency (Shepard & Gilmore, 1995).  However, cells grown in 8% glycine did not grow up to 
the required OD560 of about 0.6 within 24 hr. Growth in 4% glycine did work well, so this 
concentration was used to create all electrocompetent E. faecalis JH2-2 cells.  After growth 
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reached OD560 0.6 (log phase), cells were collected by centrifuging at 5000 rpm for 10 min in a 
Sorvall RC 5C Plus centrifuge in a GSA rotor. Cells were washed with ice cold electroporation 
buffer (0.5 M sucrose and 10% glycerol) three times (Shepard & Gilmore, 1995). The cells 
were resuspended in electroporation buffer to a volume one one-hundredth of the original 
volume and 40 μl aliquots dispensed in microcentrifuge tubes for storage in the -80 oC freezer 
(Shepard & Gilmore, 1995). 
2.3.2 Electroporation of Enterococcus faecalis JH2-2 Electrocompetent  
Cells for the Creation of Mutant divIVAEf Strains 
 Plasmid DNA (pCBWT, pMWMR5, pMWMR10, pCBMR15 or pCBMR16 (Table 
2.3)) and a 40 μl aliquot of the electrocompetent E. faecalis JH2-2 cells were incubated on ice 
for 30 min. An electroporation cuvette with a gap width of 0.2 cm was also chilled on ice for at 
least 5 min (Shepard & Gilmore, 1995).  The volume of plasmid DNA added to E. faecalis cells 
depended on the concentration of the plasmid preparation, which was eluted in ddH2O. 
Generally, no more than 3.5 μl of plasmid DNA was added to 40 μl of electrocompetent cells 
(Shepard & Gilmore, 1995). A higher volume used could reduce the transformation efficiency 
and/or result in arching of the electrical pulse due to higher salt concentrations associated with a 
higher volume.  The concentration of each plasmid transformed into E. faecalis is discussed 
below.  A pulse of 2.5 kV, 25 mF capacitance, and 200 W was applied to the cuvette containing 
cell/plasmid mixture (Shepard & Gilmore, 1995). One ml of ice cold M17 broth supplemented 
with 0.5 M sucrose, 10 mM MgCl2, and 10 mM CaCl2 (SM17MC broth) was added to the cells 
in the cuvette and the cuvette was incubated on ice for a minimum of 10 min and at 37 oC for 3 
hr (Shepard & Gilmore, 1995). Cells were collected by centrifuging at 5000 rpm for 5 min and 
resuspended in 100 μl of SM17MC broth (Shepard & Gilmore, 1995). Cells were plated on SR 
agar containing either Kan500 or Kan500 plus Ery125 depending on the plasmids transformed. 
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 The plasmid pCBWT (Table 2.3) was transformed into E. faecalis JH2-2 to ensure the 
insertion of the kan cassette into the chromosome did not affect cell growth.  The ideal amount 
of plasmid DNA required for efficient transformation into electrocompetent E. faecalis was 
determined to be between 150-1000 ng, however, the volume of DNA added to the cells could 
not exceed one-tenth the volume of the cells (as discussed above).  So, in a 40 μl aliquot of cells 
no more than 4 μl of DNA could be added.  To obtain high concentrations of plasmid DNA, 
two 50 μl plasmid preparations were run through a single PCR purification column and eluted 
with 50 μl of ddH2O to obtain a concentration of 400  ng/μl for pCBMR15, 240 ng/μl of 
pCBMR16 (Fig 2.6 A), and 200 ng/μl of pCBWT (Fig 2.6 B).  After electroporation and 
incubation, the transformed cells were plated on SR Kan500 agar and incubated at 37 oC for 18-
24 hr.  Electroporation of pMWMR5 and pMWMR10 was performed in the same manner.  
Colonies were isolated for the pCBWT transformation by streaking on a fresh SR Kan500 [the 
minimal inhibitory concentration (MIC) for E. faecalis JH2-2 was found to be 500 μg/ ml Kan 
(Ramirez-Arcos et al., 2005)] plate and incubated for 18 hr at 37 oC.  Upon 4-5 attempts no 
viable cells giving rise to E. faecalis JH2-2 colonies were obtained after transforming the 
pMWMR5, pMWMR10, pCBMR15 or pCBMR16 plasmid constructs.  For screening colonies 
transformed with pCBWT a small amount of cells was resuspended in ddH2O to use as a 
template for screening with PCR.  For screening, PCR using primers that bind 117 bp upstream 
divIVAEf, CH-F (Table 2.2) and 102 bp downstream divIVAEf, CH-R (Table 2.2) on the 
chromosome were used to check if allelic exchange was successful.  After transformation with 
pCBWT, wild type divIVAEf was present and the kan cassette was integrated into the 
chromosome immediately downstream divIVAEf (stain named E. faecalis CBWT; Table 2.1).  
This strain had a PCR fragment of about 1921 bp (Fig 2.7) containing divIVAEf, the kan  
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Figure 2.6: Gel electorphoresis for determining plasmid concentrations for Enterococcus 
faecalis JH2-2 electroporation.  A) Lane 2: pCBMR15 with a concentration of approximately 
400 ng/μl; Lane 4: pCBMR16 with an approximate concentration of 240 ng/μl.  B) Lanes 6 and 
8 are the same sample of pCBWT with an approximate concentration of 200 ng/μl.  Lane 3 and 
7: Low Mass DNA Ladder (Invitrogen). 
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Figure 2.7:  Gel electrophoresis of PCR amplification used to screen Enterococcus faecalis 
for the kanamycin cassette insert.  E. faecalis cells transformed with pCBWT was used as 
template to PCR screen for the divIVA::kan cassette insert, using chromosomal primers CH-F 
and CH-R, into the E. faecalis JH2-2 chromosome.  Sample 1 and sample 2 were positive for 
the divIVA~kan insert with an expected fragment including 117 bp upstream divIVAEf, divIVAEf, 
the kan cassette, and 102 bp downstream divIVAEf resulting in the band at ~1921 bp.  The 
picture on right is a negative control for primers CH-F and CH-R showing divIVAEf PCR 
amplified from E. faecalis JH2-2, which did not contain the kanamycin insert.   
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cassette, and 117 bp upstream and 102 bp downstream divIVAEf, respectively, due to the 
binding sites of primers CH-F and CH-R on the E. faecalis chromosome.  Those colonies 
negative for homologous recombination resulted in a PCR fragment of the 117 bp upstream 
bases, divIVAEf, and the 102 bases downstream divIVAEf to give a fragment size of 921 bp (Fig 
2.7).  The 1921 bp fragments PCR amplified from positive colonies were sent for sequencing 
(PBI) using primers CH-F, CH-R, IVA-5, CBIVA-2, CBkan-up, and CBkan-down to check 
gene integrity of divIVAEf and the kan cassette (as mentioned in section 2.2.4).  Since no 
colonies were recovered upon transformation with pMWMR5, pMWMR10, pCBMR15, or 
pCBMR16, the divIVAEf mutations MR5I37P, M43P, L46D, L50D, L57D, MR10L143P, MR15L104P, I115P, 
I125P, and MR16L104P, I115P, I125P, L143P (Table 1.1) were probably lethal.  For this reason the rescue 
method developed by Ramirez-Arcos et al was employed (Ramirez-Arcos et al., 2005).  The 
rescue plasmid pMSPSRDiv-2 (Table 2.3), which expressed wild type divIVAEf in trans, was 
co-transformed with pMWMR5, pMWMR10, pCBMR15, or pCBMR16.  Colonies resulting 
from pMWMR5 and pMWMR10 double transformed with pMSPSRDiv-2 were isolated from 
growth on SR Kan500 Ery125 agar plates and screened using the CH-F and CH-R primers as was 
done for screening with pCBWT.  The use of SR agar helped to reduce background growth 
observed when plated on BHI agar after electroporation of E. faecalis JH2-2 to transform in 
plasmid DNA.  SR agar contains per liter: 10 g trypton, 200 g sucrose, 5 g yeast extract, 25 g 
gelatin, 10 g glucose, 2.5 mM MgCl2, 2.5 mM CaCl2.  Colonies were screened for positive 
homologous recombination as was performed with E. faecalis CBWT.  Introduction of the 
MR5E37P, N43P, L46D, L50E, L57F and MR10L143P point mutations was successful.  The E. faecalis 
JH2-2 strain with the divIVAEf MR5 (E37P, N43P, L46D, L50E, L57F) point mutations was 
named E .faecals MWMR5 and E. faecalis MWMR10 carrying the divIVAEf MR10 (L143P) 
point mutation (Table 2.1).  Sequencing of the 1921 bp PCR fragment amplified from E. 
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faecalis MWMR5 and E. faecalis MWMR10 confirmed the presence of the required point 
mutations.   
Three attempts to introduce MR16L104P, I115P, I125P, L143P were unsuccessful with no 
colonies isolated.  One colony isolated from a transformation with pCBMR15 (containing 
divIVAEf MR15 L104P, I115P, I125P ) did have the appropriate 1921 bp PCR amplicon, but DNA 
sequencing showed that only the I125P point mutation was present in the chromosome.  
Additional attempts to introduce MR15 point mutations into divIVAEf were unsuccessful, so 
were probably lethal. 
2.4 Western Blots 
 Enterococcus faecalis JH2-2, E. faecalis CBWT and E. coli R721 (carrying various 
B2H plasmids) cell extracts were analyzed using sodium dodecyl sulphate polyacrylamide gel 
electrophoresis (SDS-PAGE) as developed by Sambrook et al. (1980).  To extract protein from 
log phase E. faecalis, cells were first treated with 20 mg/ml lysozyme (Sigma, Oakville, ON) 
and incubated at 37 oC for 1 hr.  Then glass beads (Sigma, Oakville, ON) were added followed 
by 5 min of vigorous mixing with a vortex (all E. faecalis strains were treated the same).  For E. 
coli and E. faecalis protein loading buffer (62.5mM Tris-HCl; pH 6.8, 2% SDS, 25% glycerol, 
0.01% bromophenol blue) was added, in a 1:5 ratio, to each sample (Sambrook, 1980).  
Samples were then boiled for 10 min., vortexed again for 2 min., and spun down at 14,000 rpm 
for a few seconds.  For E. coli and E. faecalis, whole cell extracts were run on an SDS-PAGE 
gel consisting of a 5% stacking gel and 12% resolving gel.  For electrophoresis, 10 μl of 
Precision Plus Protein dual color standard marker (Bio-Rad, Hercules, CA) and 30 μl of each 
sample was loaded on the SDS-PAGE gel and run in running buffer (5 mM Tris-HCl, 50 mM 
glycine and 0.1% SDS, pH 8.3) at 100V for 1.6 hr (until loading dye ran off the gel). The gel 
was then stained with Coomassie brilliant blue (Sambrook, 1980) for an hr and distained using 
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45% methanol (CH3OH) and 10% acetic acid solution.  Spot densitometry was performed using 
the MultiImage Light Cabinet (Alpha Innotech Corporation, San Leandro, CA) and Alpha 
Imager v5.5 software to determine approximate protein concentrations for normalized loading 
of Western blots. 
 After protein electrophoresis with standardized loading, the separated proteins in the 
SDS-PAGE gel were transferred to an Immobilon transfer membrane with a pore size of 0.45 
um (Millipore, Bedford, MA) for 90 min at 100V in transfer buffer (20% CH3OH, 10% TG 
buffer). The membrane was blocked for 1 hr at room temperature with 3% skim milk in 1x TBS 
(4x TBS: 200 mM Tris, 5M NaCl).  After blocking, the membrane was washed with TTBS (1x 
TBS with 0.05% Tween 20).  The membrane was then incubated o/n at 4 oC with primary 
DivIVAEf polyclonal antibody (Ramirez-Arcos et al., 2005) diluted 1:1000, 1:2000, and 1:4000 
in TTBS.  The next day the membrane was washed in TTBS three times and treated with 
secondary anti rabbit IgG antibody (BioRad) diluted 1:3000 in TTBS.  It was incubated for 1 hr 
at room temperature, washed three times in TTBS, and washed once in 1x TBS.  Autophos was 
added to the membrane and viewed with the MultiImage Light Cabinet (Alpha Innotech 
Corporation, San Leandro, CA) using the Alpha Imager v5.5 software. 
 2.5 Bacterial Two-Hybrid Assay 
 The Bacterial Two-hybrid system used in this study is discussed in Appendix A.  E. coli 
R721 cells were double transformed with pcI434~linker and pcI22~linker each containing gene 
inserts of proteins under study (Table 2.4).  For interaction studies between DivIVAEf and full 
length MLJD1 E. coli R721 was double transformed with pdivIVA434 / pdivIVA22 (to check 
DivIVAEf self interaction), pdivIVA434 / p22L-mljd1, and p434L-mljd1 / pdivIVA22 (Table 
2.4).  Each plasmid mentioned was also transformed into E. coli R721 alone to check 
background repression induced by each plasmid alone (negative control).  E. coli R721 with no  
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Table 2.4: The combination of plasmids transformed into Escherichia coli R721 for 
Bacterial Two-Hybrid experiments.   
B2H Plasmid 
Constructs 
pdivIVA434 p434L-mljd1 p434L-CBS1CBS2 p434L-MR16 
pdivIVA22 + + + - 
p22L-mljd1 + - - - 
p22L-CBS1CBS2 + - - + 
p22L-MR16 - - + - 
 
Note: Plasmid combinations used to study the interaction capabilities between DivIVAEf and 
full length MLJD1, DivIVAEf and the CBS containing fragment of MLJD1, and MR16L104P, 
I115P, I125P, L143P mutant DivIVAEf with the CBS containing fragment of MLJD1. 
 
+ indicates plasmids that were double transformed 
- indicates plasmids that were not double transformed 
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plasmid transformed was also used in each assay as a base measure for maximum β-
galactosidase activity.  The same was performed when studying the interaction between 
DivIVAEf and the fragment of MLJD1 containing the two CBS domains, with plasmids 
pdivIVA434, pdivIVA22, p434L-CBS1CBS2, and p22L-CBS1CBS2 (Table 2.4).  Interaction 
between the MR16L104P, I115P, I125P, L143P DivIVAEf mutant and the fragment containing the two 
CBS domains of MLJD1 was also studied, using plasmids p434L-MR16, p22L-MR16, p434L-
CBS1CBS2, and p22L-CBS1CBS2 (Table 2.3).  Each assay was performed in triplicates. 
To prepare cultures for the B2H assay, 3 ml of LB broth supplemented with 
Kan30Amp50, Kan30, or Amp50 and 30 μg/ml chloramphenicol (Cm30) for E. coli R721 with no 
plasmid, were inoculated from frozen stock and grown o/n at 37 oC and 200 rpm.  The 
following morning o/n culture was diluted 1:100, for cultures with normal growth rates, or 1:50, 
for cultures with slower growth rates, into 4 ml of fresh LB broth supplemented with 
appropriate antibiotics and 1.0 x 10-4 M IPTG.  Cultures were grown for 2.5-3 hr or until OD600 
= 0.4-0.7.  Cells were then incubated on ice for 20 min and then spun down at 6000 rpm for 10 
min. After the supernatant was discarded, cells were resuspended in 1.5 ml of cold Z-buffer 
(0.06 M Na2HPO4, 0.04 M NaH2PO4 H2O, 0.002 M KCl, 0.004 M MgSO4 7H2O, and 10.28% 
β-mercaptoethanol).  The OD600 of the cell suspension was measured with an Ultrospec 3100 
Pro (Fisher Scientific, Ottawa, ON) using 1 ml cuvettes (VWR, Mississauga, ON).  Each 
sample was diluted 1:10 to make triplicates with a final volume of 1 ml.  Cells were 
permeabilized by the addition of 0.1 ml chloroform and 0.05 ml of 0.1% SDS, vortexed and 
incubated for 5 min at 28 oC.  To start the β-galactosidase assay 4 mg/ ml of ONPG was added 
to each tube consecutively every 10 seconds and the tubes vortexed.  Once the reaction reached 
sufficient yellowing the reaction was stopped with 0.5 ml of 1 M Na2CO3, vortexed, and the 
stop time recorded.  Samples were centrifuged at 14,000 rpm to pull cell debris and chloroform 
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to the bottom of the tube and 1 ml of the supernatant was dispensed into a cuvette.  The OD420 
and OD550 were recorded and Miller units were determined using the following equation: Miller 
units = 1000 x [(OD420 – 1.75) x OD550] / (T x V x OD600) where T = reaction time in min and 
V = volume of culture used in assay tubes in ml.  The percentage of reduced β-galactosidase 
activity was calculated as in the following sample calculation: % reduction = ((R721 control 
(Miller Units) -DivIVAEf~DivIVAEf (Miller Units) / R721 control) x 100 = ((1842.74 – 884.06) 
/ 1842.74) x 100 = 52%.  The threshold for determining protein-protein interaction was 50%, 
where >50% reduction in β-gal activity indicates positive interaction and <50% reduction 
indicates no or uncertain interaction (Di Lallo et al., 2003, Fadda et al., 2007). 
2.6 Microscopy of Enterococcus faecalis Strains JH2-2, JH2-2+R, CBWT, 
MWMR5 and MWMR10 
 2.6.1 Differential Interference Contrast Light Microscopy 
For Differential Interference Contrast (DIC) light microscopy E. feacalis strains JH2-2, 
JH2-2+R (JH2-2 with rescue vector pMSPSRDiv-2 containing divIVAEf and its own promoter 
(Table 2.1)), CBWT, MWMR5, and MWMR10 were cultured over night for stationary cultures 
or for 6-7 hr (or until the culture reached OD560 0.6) for log phase cultures (Shepard & Gilmore, 
1995) in BHI broth supplemented with no antibiotics, 1000 μg/ml Kan, 125 μg/ml Ery, or 1000 
μg/ml Kan plus 125 μg/ml Ery.  Cells were fixed with 0.2% gluteraldehyde and 6% 
formaldehyde and transferred to 0.1% Poly-L-Lysine  (Sigma-Aldrich Co., St. Louis, MO) 
coated cover slips (Ramirez-Arcos et al., 2001b).  To stain chromosomal DNA, about 3 μl of 
0.2 μg/ ml of 4',6-diamidino-2-phenylindole (DAPI) stain was incubated on the cover slips for 
1.5-2 min and then rinsed off with 1x PBS.  Cover slips containing fixed cells were placed on 
glass slides containing a drop of 50% glycerol (Ramirez-Arcos et al., 2001b) and the edges of 
the cover slip were sealed with clear nail polish to prevent the sample from drying out.  Over 
 54
500 cells were examined for each strain and with an Olympus BX61 microscope.  Images were 
taken using a Photometrics CoolSnap ES camera with ImagePro Version 5 Software (Media 
Cybernetics, Bethesda, MD) and In Vitro (Media Cybernetics) software.  The experiment was 
performed twice for each strain (Rigden et al., 2008). 
 2.6.2 Transmission Electron Microscopy 
 To prepare E. faecalis JH2-2, CBWT, MWMR5 and MWMR10 for transmission 
electron microscopy, cultures were first grown over night to stationary phase at 37 oC, with no 
shaking, in BHI broth supplemented with 1000 μg/ml Kan, 125 μg/ml Ery, or 50 μg/ml Kan 
plus 125 μg/ml Ery  (for strains CBWT, MWMR5 and MWMR10).  E. faecalis JH2-2 required 
no antibiotic supplementation.  Cells were grown to log phase (6-7 hr) and 3 ml were pellated 
by centrifuging at 5,000 rpm for 5 min.  Collected cells were washed in 0.01 M Na-cacodylate 
buffer and 38 μl of 25% glutaraldehyde was added.  Cells were left at 4 oC overnight to fix.  
Cells were washed in 0.01 M Na-cacodylate buffer twice more, resuspended in 0.01 M Na-
cacodylate buffer and shipped on ice to the Electron Microscopy Unit, Surgical Medical 
Research Institute, University of Alberta (Edmonton, Alberta).  Dr. Ming Chen further 
processed the samples and performed Transmission Electron Microscopy (TEM) using a 
Hitachi Transmission Electron Microscope H-7000 and mailed the negatives back to our 
laboratory for analysis. 
2.6.3 Statistical Analysis of DIC and TEM Micrographs of Enterococcus 
faecalis JH2-2, JH2-2+R, CBWT, MWMR5 and MWMR10 
 Wild type Enterococcus faecalis JH2-2 cells were defined as diplococci with a 
characteristic lancet shape in DIC and TEM micrographs.  For DIC microscopy, 500 or more 
cells were counted in consecutive microscopy fields and defined as either normal (diplococci 
lancet shaped) or aberrant (enlarged spheres, short chains, and irregular shapes) (Rigden et al., 
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2008).  Using the chi-square test comparing E. faecalis JH2-2+R, CBWT, MWMR5 and 
MWMR10 to E. faecalis JH2-2, P-values were determined.  P-values were considered 
significant if they were < 0.05.   
For the TEM micrographs a lancet shape was identified as the ratio of pole-to-pole 
length (x) versus the length between the two edges at the division site (y) to be x/y > 1.50 
(Rigden et al., 2008).  Cells with an x/y < 1.50 were considered spherical (Rigden et al., 2008).  
Again, lancet shaped diplococci were considered normal while spherical shape, short chains, 
and asymmetrical division were counted as aberrant (Rigden et al., 2008).  Counting 40-60 
cells, E. faecalis CBWT, MWMR5 and MWMR10 were compared to E. faecalis JH2-2 using 
the chi-square test to determine the P-values (Rigden et al., 2008).  P-values of <0.05 were 
considered significant.  Enterococcus faecalis JH2-2+R were previously defined as having the 
normal lancet shaped diplococci phenotype as compared to E. faecalis JH2-2 in TEM 
micrographs (Ramirez-Arcos et al., 2005).   
2.6.4 Immunoflorescence Microscopy for Determining DivIVAEf and 
MLJD Localization in Enterococcus faecalis JH2-2 
Enterococcus faecalis JH2-2 were fixed as described by Morlot et al. (2003).  Briefly, 
cells were grown in 3 ml of BHI broth (Difco) at 37 oC o/n without agitation.  The following 
day an o/n culture was diluted 1:100 into 5 ml of fresh BHI broth and grown to an OD600 ~ 0.6 
(approximately 5 hr to log phase). Cells were collected by centrifuging at 10,000 g for 15 min 
at 4 oC.  Collected cells were washed with 30 mM phosphate buffer (pH 7.0) three times. Cells 
were then fixed in 1 ml of 2.5% paraformaldehyde and 0.03% glutaraldehyde for 15 min at 
room temperature and 2 hr on ice (Morlot et al., 2003).  Cells were washed three more times in 
1x PBS and stored in 0.5 ml 1x PBS at 4 oC.  Cells were stained as in Fadda et al. (2007).  
Fixed cells were first transferred to 0.1% Poly-L-Lysine coated cover slips.  Cover slips were 
 56
washed twice with 1x PBS, air dried, and dipped in -20 oC CH3OH for 10 min.  They were then 
blocked for 1 hr at room temperature with BSA-PBST (2% BSA and 0.2% TritanX-100 in 1x 
PBS).  Next, slides were incubated with 1:50 and 1:200 dilutions of primary anti-DivIVAEf 
rabbit antibody (Ramirez-Arcos et al., 2005) for 4 hr.  Slides were washed 4-5 times with PBST 
and incubated with 1:600 dilution of secondary anti-rabbit IgG Alexa Fluor 488 (Sigma) for 45 
min at room temperature in the dark.  Cells were stained with DAPI as in section 2.6.1. 
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3.0 Results 
3.1 Phenotype Determination of divIVAEf Mutant Enterococcus faecalis Strains 
MWMR5 and MWMR10 
 Disruption of the DivIVAEf N-terminal coiled-coil and oligomerization  was shown to 
be lethal, as introduction of the MR5E37P, N43P, L46D, L50E, L57F  and MR10L143P point mutations into 
E. faecalis JH2-2 chromosomal divIVAEf resulted in no bacterial growth.  divIVAEf MR5 E37P, 
N43P, L46D, L50E, L57F and MR10L143P were successfully introduced into E. faecalis JH2-2 
chromosomal divIVAEf when rescued by in trans expression of wild type divIVAEf by the 
pMSPSRDiv-2 rescue vector.   
Expression of wild type DivIVAEf from the rescue vector in E. faecalis MWMR5 was 
unable to fully restore the wild type phenotype, described as being lancet shaped diplococci 
(Ramirez-Arcos et al., 2005).  Differential Interference Contrast (DIC) microscopy showed E. 
faecalis MWMR5 cells with aberrant growth, characterized by spherical cells (arrows, Fig 3.1 
B), short chains, and cells with irregular shapes (arrowheads, Fig 3.1 B) as compared to wild 
type E. faecalis JH2-2 (Fig 3.1A).  Statistical analysis comparing 549 cells of E. faecalis 
MWMR5 to 580 cells of E. faeclis JH2-2 demonstrated that a significant percentage (ie: 50% 
with a P-value of <0.01 being significant) of E. faecalis MWMR5 cells had aberrant 
morphology (black bars, Fig 3.1 D).  Transmission Electron Microscopy (TEM) of E. faecalis 
MWMR5 also showed a significant percentage, about 80% of the cells, with aberrant 
morphology (black bars, Fig 3.2 D), with a P-value of <0.05 being significant.  The aberrant 
morphology was defined as asymmetrical septum placement in ~1-2% of cells (arrowheads, Fig 
3.2 B), spherical shape in ~70% of cells, or aberrant septation resulting in irregular short chains 
in ~8% of cells (arrows, Fig 3.2 B). 
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Figure 3.1: Differential Interference Contrast microscopy of Enterococcus faecalis JH2-2, 
MWMR5, and MWMR10 strains. A) E. faecalis JH2-2, B) E. faecalis MWMR5, and C) E. 
faecalis MWMR10.  A, B, and C are of the same magnification.  Arrows indicate enlarged 
round cells while the arrow heads indicate irregular cells in chains.  D) Percentage of E. 
faecalis strains; white bars- % of normal lancet shaped cells; black bars- % of cells with 
aberrant morphology (enlarged spheres, irregular shape, and short chains).  “n” is the number of 
cells counted for each strain. 
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0 1  2  3
Microns
0 1  2  3
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Figure 3.2: Transmission electron microscopy of Enterococcus faecalis strains JH2-2, 
MWMR5, and MWMR10.  A) E. faecalis CBWT, B) E. faecalis MWMR5, and C) E. faecalis 
MWMR10.  The scale bar in (bottom right corner) represents 1 micron and images (A), (B), 
and (C) are of the same magnification.  Arrowheads in (B) indicate asymmetrical septum 
placement while arrows in (B) and (C) indicates short chains of irregular cells.  D) Percentage 
of cells with wild type lancet dipplococci (white bars) and percentage of cells with aberrant cell 
morphology (spherical, asymmetrical division, and irregular short chains; black bars).  P values 
were calculated using the chi-square test comparing E. faecalis CBWT, MWMR5 and 
MWMR10 to JH2-2.  A P value of <0.05 is considered significant.  “n” represents the number 
of cells counted. 
A.
B.
C.
D.
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Similar results were found in the case of E. faecalis MWMR10, where wild type 
DivIVAEf expressed from the rescue vector was again unable to fully restore the wild type 
phenotype.  The DIC micrographs showed E. faecalis MWMR10 cells (Fig 3.1 C) had aberrant 
growth defined by spherical cells (arrows, Fig 3.1 C), short chains and cells with irregular 
shapes (arrowheads, Fig 3.1 C) as compared to E. faecalis JH2-2 (Fig 3.1 A).  The TEM 
micrographs of E. faecalis MWMR10 (Fig 3.2 C) demonstrated that DivIVAEf carrying 
MR10L143P resulted in a significant percentage of cells with aberrant morphology (black bars, 
Fig 3.2 D) defined as asymmetrical division, spherical shape, and irregular cells in short chains 
(arrows, Fig 3.2 C) as compared to E. faecalis JH2-2 (Fig 3.2 A) with a normal lancet shape 
and midcell septum placement (white bars, Fig 3.2 D) (Rigden et al., 2008). 
By comparison of E. faecalis MWMR5 and E. faecalis MWMR10, E. faecalis JH2-2+R 
(Table 2.1) and E. faecalis CBWT had a significant number of lancet shaped cells with 
symmetrical division (Fig 3.1 D; Fig 3.2 D).  These results demonstrated that the rescue vector 
in E. faecalis JH2-2+R and the kanamycin cassette in E. faecalis CBWT did not affect bacterial 
cell division in these strains (Rigden et al., 2008, Ramirez-Arcos et al., 2005).  The results thus 
implicate the essentiality of the N-terminal coiled-coil region and oligomerization of DivIVAEf 
in E. faecalis cell division. 
 3.2 Localization of DivIVAEf and MLJD1 in Enterococcus faecalis 
  3.2.1 Localization of DivIVAEf 
Five stages of cell division were defined for E. faecalis cells in log phase growth (Fig 
3.3).  The first stage was defined as a single cell with a central chromosome.  Stage two was 
represented as the single chromosome appearing larger and elongated as the single cell began to 
divide, seen by a small indentation at the midcell site (Fig 3.3).  The third stage of cell division 
was defined as when two newly replicated and segregated chromosomes were evident.  At this  
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Figure 3.3: Representation of five stages of Enterococcus faecalis JH2-2 cell division.  
Stages were defined by interpretation of DIC micrographs, DAPI staining of the chromosome, 
and DivVIAEf and MLJD1 localization patterns.  Diagram on the right is not to scale. 
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stage the septum at the midcell site was more constricted, as seen by greater indentation at this 
site.  As the septum further constricted and the chromosomal DNA condensed, the cells reached 
Stage 4.  In Stage 5 the two daughter cells appeared to be separated by the septum, but 
remained attached together as diplococci (Fig 3.3).  The chromosome of each new daughter cell 
was also beginning to elongate to initiate the next round of cell division.  
For DivIVAEf localization in E. faecalis JH2-2, out of 273 cells counted, the percentage 
of cells at each stage of cell division was calculated (Fig 3.4).  To determine the localization of 
DivIVAEf in E. faecalis JH2-2 cells, immunofluorescence using primary anti-DivIVAEf 
antibody and Aluxa Fluor 488 secondary antibody was utilized.  In Stage 1 of cell division, 
20.5% of the cells counted, DivIVAEf appeared equally distributed along the entire inner 
membrane (Fig 3.4 Stage 1).  As the cells began to divide, 16.1% of the cells counted, 
DivIVAEf started to concentrate to the cell poles (Fig 3.4 Stage 2).  26.4% of the cells counted 
were in Stage 3 where DivIVEf appeared as caps at the “cell poles” (Fig 3.4 Stage 3).  Stage 2 
and 3 were very similar, the main difference being the state of chromosomal segregation.  In 
Stage 4 of cell division DivIVAEf was localized to both the “cell poles” and concurrently at the 
division site, which represented 16.8% of the cells counted (Fig 3.4 Stage 4).  A diagram 
depicting DivIVAEf localization is in Figure 3.5. 
3.2.2 Localization of MLJD1 
Immunofluorescence was performed to determine the localization of MLJD1 in E. 
faecalis JH2-2 cells similar to DivIVAEf, but with primary antibi-MLJD1 primary antibody.  
Cells were again counted and separated into five stages of cell division.  MLJD1 appeared to 
localize differently from DivIVAEf at stages 2 and 3 of cell division.  38.1% of cells were in 
Stage 1 of cell division and showed MLJD1 to be dispersed throughout the inner membrane of  
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Figure 3.4: Immunoflorescence localization of DivIVAEf in Enterococcus faecalis JH2-2.  
Differential Interference Contrast (DIC) microscopy; 4'-6-diamidino-2-phenylindole (DAPI) 
staining of chromosomal DNA; Alexa Fluor 488 secondary anti-rabbit antibody bound to 
primary anti-DivIVAEf antibody fluoresced green to detect localization of DivIVAEf.  Log 
phase cells (273) were counted and the percentage of cells in each stage of cell division 
determined. 
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Figure 3.5: Interpretation of DivIVAEf localization in E. faecalis JH2-2.  Green represents 
DivIVAEf, while red represents the chromosome. 
 
 
 
Cell Division 
Stage
1
2
3
4
5
Cell Division
Stage Interpretation
 65
the cells, similar to DivIVAEf (Fig 3.6 Stage 1).  As the cells progressed through Stage 2 and 3 
of cell division, 27.4% of the cells counted, MLJD1 appeared to localize along the length of the 
cell rather than to the cellular poles (Fig 3.6 Stage 2 and 3).  In 22.8% of the cells counted, the 
chromosomes were completely segregated (appearing as two separate entaties) and the septum 
was more defined and constricted.  In this stage, Stage 4, MLJD1 localized to the cell poles or 
along the cell length (difficult to distinguish) and concurrently at the division site (Fig 3.6 Stage 
4), as was the case with DivIVAEf (Fig 3.4 Stage 4).  As cell division completed in Stage 5, 
11.7% of the cells, MLJD1 became dispersed along the inner membrane once more (Fig 3.6 
Stage 5).  These results suggest MLJD1 may co-localizes with DivIVAEf in E. faecalis during 
later stages of cell division.   
 3.2.3 Potential Co-localization of DivIVAEf and MLJD1 in 
Enterococcus faecalis JH2-2 
 The localization patterns of DivIVAEf and MLJD1 in E. faecalis JH2-2 were somewhat 
different.  For each localization study, cells were grown to log phase (6-7 hr or until the culture 
reached OD560 0.6 (Shepard & Gilmore, 1995)).  A percentage of cells in Stage 1 of cell 
division were more than double the percentage of cells in Stage 5 of cell division for MLJD1 
localization studies (Table 3.1).  This indicates the culture was in log phase growth (Haeusser & 
Levin, 2008).  For the cultures used for DivIVAEf localization there was an equal amount of 
cells in Stage 1 and Stage 5, indicating they may have not been in mid-log phase at the time the 
cells were fixed.  For future studies using Immunofluorescense in E. faecalis it would be useful 
to determine the actual replication time in a particular media with consistent growth conditions 
(temperature).  It would also be useful to utilize synchronized cell cultures for use in future co-
localization studies for MLJD1 and DivIVAEf in E. faecalis (see Discussion). 
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Figure 3.6: Immunofluorescence of MLJD1 localization in Enterococcus faecalis JH2-2.  
Differential Interference Contrast (DIC) microscopy; 4'-6-diamidino-2-phenylindole (DAPI) 
staining of chromosomal DNA; Alexa Fluor 488 secondary anti-rabbit antibody bound to 
primary anti-MLJD1 antibody fluoresced green to detect localization of MLJD1.  281 log phase 
cells were counted and the percentage of cells in each stage of cell division determined. 
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Table 4.1: Percentage of cells in each of five cell division stages for DivIVAEf and MLJD1 
localization studies in Enterococcus  faecalis 
 
Stage of Cell Division 
% of Cells Counted in 
DivIVAEf Localization Study 
% of Cells Counted in 
MLJD1 Localization Study 
1 20.5% 38.1% 
2 and 3 42.5% 27.4% 
4 16.8% 22.8% 
5 20.1% 11.7% 
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3.3 DivIVAEf Self-Interaction and Interaction with MLJD1, a Novel Division 
Protein, using a Bacterial Two-Hybrid System 
3.3.1 DivIVAEf Interaction with Full Length MLJD1 
The interaction between full length MLJD1 and DivIVAEf was very weak in the Yeast 
Two-Hybrid (Y2H) studies used to screen the E. faecalis JH2-2 genomic library (Liao et al., 
manuscript in preparation).  Instead, a fragment of MLJD1, containing the two CBS domains, 
demonstrated interaction capabilities with DivIVAEf (Liao et al., manuscript in preparation).  
The Bacterial Two-Hybrid (B2H) system has been determined to detect interaction between 
bacterial proteins previously undetected in the Y2H system (Di Lallo et al., 2001).  For this 
reason, DivIVAEf self interaction and DivIVAEf interaction with full length MLJD1 were 
examined using the B2H developed by Di Lallo (Di Lallo et al., 2001).  Figure 3.7 shows the 
average of 3-4 B2H assays, as indicated, each of which was done in triplicate.  Interaction was 
positive if there was 50% or greater reduction of β-galactosidase (β-gal) activity as compared to 
the E. coli R721 control (without plasmid).  E. coli R721 without plasmid represented the 
maximum β-gal activity (Fig 3.7).  Reading Fig 3.7 from left to right, the data represented in the 
first bar indicates a positive DivIVAEf self interaction which reduced β-gal activity by 52%.  
The data represented by the second and third bars in Fig 3.7 were examining the interaction 
capabilities between DivIVAEf and MLJD1, representing both plasmid combinations.  The data 
represented in the second bar suggests DivIVAEf does not interact with full length MLJD1, with 
a 35% reduction in β-gal activity.  Contradicting the data in the second bar, the third bar data 
shows 56% reduced β-gal activity, indicating positive interaction between DivIVAEf and full 
length MLJD1 (Fig 3.7).  While the data depicted in the fourth and fifth bars ensure there is no 
background reduction of β-gal activity induced by either plasmid carrying divIVAEf, the data in  
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Figure 3.7: DivIVAEf Self-interaction and Interaction with Full Length MLJD1 in a 
Bacterial Two-hybrid system.  The y-axis is β-galactosidase activity measured in Miller Units.  
Along the x-axis bars represent β-gal activity within E. coli transformed with the indicated 
plasmids for examining the following protein-protein interactions: vertical lines- DivIVAEf self 
interaction; spaced dots (bar 2 and 3)- DivIVAEf interaction with full length MLJD1; thatched 
lines (bar 4 and 5)- single plasmid controls expressing DivIVAEf fusion proteins; tight spaced 
dots (bar 6 and 7)- single plasmid controls expressing MLJD1 fusion proteins; and solid green 
(bar 8) is E. coli R721 with no transformed plasmids indicating maximum β-gal activity.  %R = 
percent reduction of β-galactosidase activity; >50% indicates positive interaction.  The B2H 
assays were performed as in section 2.5. The results represent four independent B2H assays; a 
(*) indicates average of three B2H assays and each assay was performed in triplicates. 
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the data represented by the sixth and seventh bars do demonstrate background β-gal reduction 
for plasmids carrying mljd1.  The plasmids p434L-mljd1and p22L-mljd1 induced 87% and 41% 
reduced β-gal activity, indicating that protein products from each plasmid alone could have 
been capable of reducing β-gal activity.  The reduction observed in the data in bar 3 of Fig 3.7 
could be a false positive due to background repression.  For this reason, these results could not 
determine the interaction capabilities between DivIVAEf and full length MLJD1. 
3.3.2 DivIVAEf Interaction with the CBS1 and CBS2 domains of MLJD1 
 MLJD1 is composed of a potential DNA binding helix-turn-helix (HTH) domain and 
two cystathionine-beta-synthase (CBS) domains (Fig 1.4).  The potential for MLJD1 to bind 
DNA could have affected the B2H result of DivIVAEf interaction with full length MLJD1 (Fig 
3.7).   This could have also affected the original Y2H, in which MLJD1 was discovered, where 
the fragment of MLJD1 containing the CBS1 and CBS2 domains and not the DNA binding 
domain showed interaction with DivIVAEf (Liao et al., unpublished data).   For this reason, the 
gene fragment containing the sequence for the two CBS domains (sequence encoding amino 
acids 79-199 of MLJD1) were cloned into the B2H plasmids and their interaction capabilities 
with DivIVAEf studied.  Figure 3.8 is the average of two B2H assays.  From left to right, the 
data in bar one in Fig 3.8 again DivIVAEf showed positive interaction, with reduced β-gal 
activity of 64%.  Unlike with full length MLJD1 (ie: Fig 3.7), interaction of the MLJD1 
fragment which included the CBS1CBS2 domains with DivIVAEf indicated positive interaction 
for both plasmid combinations (Fig 3.8).  The data in the second and third bars demonstrated a 
reduction of β-gal activity by 86% and 62%, respectively, both indicating strong interaction 
between DivIVAEf and the CBS1CBS2 domain containing fragment of MLJD1 (Fig 3.8).  
Further more, data in bars 4-7 indicate there was no significant background repression induced  
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Figure 3.8: DivIVAEf interaction with MLJD1 CBS Domains using a Bacterial Two-
hybrid system.  The y-axis is β-galactosidase activity measured in Miller Units.  Along the x-
axis bars represent β-gal activity within E. coli transformed with the indicated plasmids for 
examining the following protein-protein interactions: vertical lines- DivIVAEf self interaction; 
spaced dots (bar 2 and 3)- DivIVAEf interaction with the CBS containing fragment of MLJD1; 
thatched lines (bar 4 and 5)- single plasmid controls expressing DivIVAEf fusion proteins; tight 
spaced dots (bar 6 and 7)- single plasmid controls expressing the CBS fragment of MLJD1 
fusion proteins; and solid green (bar 8) is E. coli R721 with no transformed plasmids indicating 
maximum β-gal activity.  %R = percent reduction of β-galactosidase activity as compared to E. 
coli R721; >50% indicates positive interaction.  B2H assays were the results two independent 
β-galactosidase assays each done in triplicate.  DivIVAEf self-interaction was used as a positive 
control. 
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by any of the single plasmid controls for both DivIVAEf self interaction and DivIVAEf 
interaction with the fragment of MLJD1.  The positive interaction between DivIVAEf and the 
CBS domain containing fragment of MLJD1 can thus be recognized as a true positive 
interaction. 
3.3.3 Interaction between the MR16 Mutant DivIVAEf and the 
fragment of MLJD1 containing the two CBS domains 
 Previous work indicated that MLJD1 interacts between amino acids (aa) 60-130 of 
DivIVAEf, (Rigden, 2005).  The first central coiled-coil is from aa 100-150 and is involved in 
oligomerization.  So, MLJD1 most likely interacts with DivIVAEf between aa 60-100.  Due to 
the close proximity of this region to the central coiled-coil, DivIVAEf oligomerization may be 
an important aspect of DivIVAEf interaction with MLJD1.  For this reason the DivIVAEf mutant 
MR16L104P, I115P, I125P, L143P, which disrupts oligomerization (Rigden et al., 2008), interaction 
capabilities with the fragment, containing the two CBS domains of MLJD1 was examined using 
the same B2H assay used to confirm DivIVAEf~MLJD1 (fragment) interaction (Fig 3.8). 
 One B2H assay was performed which demonstrated a potential loss of interaction 
between DivIVAEf MR16L104P, I115P, I125P, L143P and the CBS containing MLJD1 fragment (Fig 
3.9).  In Fig 3.9, data represented in bar one indicated DivIVAEf self-interaction with 66% 
reduced β-gal activity.  The data in the second and third bars again demonstrated positive 
interaction between DivIVAEf and the CBS fragment of MLJD1, with 91% and 70% reduced β-
gal activity, respectively.   Data in bar four, where wild type DivIVAEf has been replaced with 
DivIVAEf MR16L104P, I115P, I125P, L143P, there appeared to be a loss of interaction with the MLJD1 
fragment (Fig 3.9).  However, data in the fifth bar, containing the opposite plasmid constructs, 
appeared to indicate DivIVAEf MR16L104P, I115P, I125P, L143P and the CBS containing fragment 
conserved their interaction capabilities (with 61% reduced β-gal activity; Fig 3.9). 
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Figure 3.9: Interaction of mutant DivIVAEf MR16L104P, I115P, I125P, L143P with MLJD1 CBS 
domains using Bacterial Two-hybrid system.  The y-axis is β-galactosidase activity measured 
in Miller Units.  Along the x-axis bars represent β-gal activity within E. coli transformed with 
the indicated plasmids for examining the following protein-protein interactions: bar 1- 
DivIVAEf self interaction; bar 2 and 3- DivIVAEf interaction with the CBS containing fragment 
of MLJD1; bar 4 and 5- DivIVAEf MR16 mutant interaction with the CBS containing fragment 
of MLJD2;  bars 6 and 7- single plasmid controls expressing wild type DivIVAEf fusion 
proteins; bars 8 and 9- single plasmid controls expressing the CBS fragment of MLJD1 fusion 
proteins; bars 10 and 11- single plasmid controls expressing DivIVAEf MR16 mutant fusion 
proteins; and solid green (bar 12) is E. coli R721 with no transformed plasmids indicating 
maximum β-gal activity.  %R = percent reduction of β-galactosidase activity as compared to E. 
coli R721; >50% indicates positive interaction.  The results represent a single B2H β-
galactosidase assays done in triplicates.  DivIVAEf self-interaction and interaction with the CBS 
domains of MLJD1 was used as a positive control. 
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The single plasmid controls for DivIVAEf self-interaction and interaction with the CBS 
containing fragment, data in bars 6-9 (Fig 3.9), demonstrated minimal background repression.  
Both single plasmid controls for DivIVAEf MR16L104P, I115P, I125P, L143P had 56% and 65% 
background repression, data represented by bars 10 and 11 respectively.  The repression 
observed by the data represented in bar 5 could thus be due to the effects of the background 
repression induced by the p22L-MR16 protein product.  For this reason and because only one 
assay of results, no conclusions could be made regarding DivIVAEf  MR16L104P, I115P, I125P, L143P 
interaction with the fragment of MLJD1 containing the two CBS domains. 
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4.0 Discussion 
4.1 The Essentiality of DivIVAEf Oligomerization and the N-terminal Coiled-
Coil for Proper Biological Function in Enterococcus faecalis Cell Division 
 DivIVA was first discovered and extensively studied as a cell division protein in 
Bacillus subtilis (Reeve et al., 1973).  DivIVA is now recognized as a Gram-positive cell 
division protein with homologues in Gram-positive organisms such as Streptomyces coelicolor, 
Streptococcus pneumoniae, Staphylococcus aureus, Brevibacterium lactofermentum and 
Enterococcus faecalis (Ramirez-Arcos et al., 2005, Fadda et al., 2007, Pinho & Errington, 
2004, Ramos et al., 2003, Flardh, 2003a).  Predictions of the DivIVA structure in these and 
other Gram-positive organisms indicate a coiled-coil structure (Rigden et al., 2008, Edwards et 
al., 2000, Rigden, 2005, Fadda et al., 2007).  Coiled-coil structures are responsible for 
oligomerization in a multitude of proteins and can be involved in interaction with heterologous 
proteins as well (Edwards et al., 2000, Fadda et al., 2007, Lupas, 1996b, Lupas, 1996a, Lupas 
et al., 1991).  DivIVA in E. faecalis (DivIVAEf) was determined to have four coiled-coils, one 
at the N-terminal, two in the central region, and one at the C-terminal (Rigden et al., 2008, 
Rigden, 2005).  The two central coiled-coils are involved in oligomerization, giving DivIVAEf 
the capability of forming a complex comprised of 10-12 monomers (Rigden et al., 2008, 
Rigden, 2005).  DivIVA in B. subtilis (DivIVABs) also forms a complex of up to 10-12 
monomers, although DivIVABs contains two coiled-coils, one at the N-terminal and one in the 
central region (Muchova et al., 2002b, Muchova et al., 2002a).  A point mutation in DivIVABs 
at L120P resulted in reduced oligomerization capability by 50% (Muchova et al., 2002b).  The 
corresponding mutation in DivIVAEf L143P (MR10) formed a complex of 4 monomers instead 
of the typical 10-12 monomer complex, but was able to interact with wild type DivIVAEf as 
determined by Y2H assays (Rigden et al., 2008, Rigden, 2005).   
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In the present study, E. faecalis MWMR10 contained an L143P point mutation in 
chromosomal divIVAEf, but required rescuing via in trans expression of wild type (wt) divIVAEf.  
Although E. faecalis MWMR10 was viable when rescued, wt DivIVAEf was unable to restore 
the mutant to the wt phenotype.  The inability of wt DivIVAEf to fully restore the wt phenotype 
of E. faecalis MWMR10 could have been due to differences in expression levels of divIVAEf 
compared to wt expression from the E. faecalis JH2-2 chromosome, which was also seen when 
divIVAEf was inactivated by insertion of the kan cassette (Ramirez-Arcos et al., 2005).  On the 
chromosome divIVAEf expression might be controlled by two promoters, its own and the ftsAEf 
promoter, while the rescue plasmid only carries the divIVAEf promoter (Ramirez-Arcos et al., 
2005). DivIVAEf MR10L143P and wt DivIVAEf would not occur in the same cell in nature 
because there is only one copy of divIVAEf on the chromosome.  In E. faecalis MWMR10, 
where both DivIVAEf MR10L143P and wt DivIVAEf are present, their interaction, as shown in 
Y2H assays (Rigden, 2005), could have been preventing wt DivIVAEf from carrying out its 
functions in normal cell division.  Thus, it is likely that with most of the small amount of wt 
DivIVAEf bound and inactivated by DivIVAEf MR10L143P, the mutant phenotype could be 
observed.  Differential Interference Contrast (DIC) microscopy and Transmission Electron 
Microscopy (TEM) showed  that a significant percentage of E. faecalis MWMR10 cells had 
lost their typical lancet shape, formed short chains with irregular shaped cells, and presented 
asymmetrical division (Fig 3.1 and Fig 3.2)  (Rigden et al., 2008).   
Further disruption of DivIVAEf oligomerization with multiple point mutations L104P, 
I115P, I125P (MR15) in the first central coiled-coil or L104P, I115P, I125P, L143P (MR16) in 
the first and second central coiled-coils, resulted in complete abolition of oligomerization 
(Rigden et al., 2008, Rigden, 2005).  The MR15L104P, I115P, I125P DivIVAEf mutant retained its 
ability to oligomerize with wt DivIVAEf, but was incapable of oligomerizing with itself 
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(Rigden, 2005, Rigden et al., 2008).  The MR16L104P, I115P, I125P, L143P DivIVAEf mutant was a 
combination of MR10L143P and MR15L104P, I115P, I125P point mutations which disrupted both 
central coiled-coils and resulted in loss of oligomerization with both wt and itself  (Rigden et 
al., 2008, Rigden, 2005).  Attempts to introduce the MR15 and MR16 point mutations into the 
E. faecalis JH2-2 chromosome proved to be lethal even with in trans expression of wild type 
divIVAEf.  The dominant lethal phenotype of MR15L104P, I115P, I125P and MR16L104P, I115P, I125P, L143P 
mutant DivIVAEf emphasizes the essentiality of the central coiled-coils and oligomerization of 
DivIVAEf in E. faecalis bacterial cell division (Rigden et al., 2008). 
Disruption of the N-terminal coiled-coil of DivIVAEf in E. faecalis MWMR5, with point 
mutations E37P, N43P, L46D, L50E, and L57F (MR5), did not disrupt oligomerization, but 
was also unable to be introduced into the E. faecalis chromosomal divIVAEf without rescuing by 
in trans supplementation with wt DivIVAEf (Rigden et al., 2008).  Again wt DivIVAEf was not 
able to fully restore the wt phenotype and DIC and TEM microscopy showed that a significant 
percentage of E. faecalis MWMR5 mutant cells contained spherical and irregular shapes, short 
chains, and asymmetrical division (Fig 3.1; Fig 3.2) (Rigden et al., 2008).  Previously, a 
mutation at A78T in the N-terminal of B. subtilis DivIVABs, but outside its N-terminal coiled-
coil, resulted in an anucleated minicell phenotype similar to the DivIVABs knockout (Cha & 
Stewart, 1997, Perry & Edwards, 2004, Rigden et al., 2008).  The same mutation (A78T) at the 
same A78 N-terminal location in S. pneumoniae DivIVASp resulted in dispersed localization of 
DivIVASp, a “chainy” phenotype, and loss of interaction with later divisome proteins FtsK, 
FtsL, FtsQ, FtsB, and FtsW (Fadda et al., 2007).  The N-terminal of B. subtilis DivIVABs also 
possesses two polar targeting determinants R18 and G19, which are not in the N-terminal 
coiled-coil (Perry & Edwards, 2004).  R18 and G19 are required by DivIVABs to sequester the 
MinCD FtsZ inhibitor complex to the cell poles; however, E. faecalis does not possess Min 
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proteins (Perry & Edwards, 2004, Rigden et al., 2008, Ramirez-Arcos et al., 2005).  This 
present study focused on the N-terminal coiled-coil and demonstrates the N-terminal coiled-coil 
is essential for DivIVAEf biological function in E. faecalis cell division.   
Although research has previously demonstrated that DivIVA oligomerizes to form 
complexes of 10-12 monomers (Rigden, 2005, Rigden et al., 2008, Muchova et al., 2002b, 
Muchova et al., 2002a), this study is the first instance where DivIVA oligomerization has been 
proven to be essential for the proper biological function of DivIVA in bacterial cell division.  
The next step for developing a cell division model involving DivIVA would be to determine the 
exact functions which oligomerization and the N-terminal coiled-coil play.  To elucidate if the 
N-terminal coiled-coil plays any role in localization of DivIVAEf, I would put a GFP tag on the 
MR5E37P, N43P, L46D, L50E, L57F DivIVAEf mutant within E. faecalis MWMR5.  This would allow 
the visualization of the localization of mutant DivIVAEf.  Using GFP can be difficult due to the 
small size of E. faecalis cells, so immunofluorescence could be utilized instead. One could also 
study the interaction capabilities between divisome proteins FtsZ, FtsQ, or FtsW and DivIVAEf 
MR5E37P, N43P, L46D, L50E, L57F to check if the N-terminal coiled-coil is involved in these 
interactions. 
To further study the function of DivIVAEf oligomerization I examined the interaction 
capabilities of DivIVAEf MR16 with the novel putative division protein MLJD1 (discussed 
below). 
4.2 DivIVAEf Self Interaction and Interaction with MLJD1 
 The interaction between DivIVAEf and a novel cell division protein MLJD1 was 
discovered in our laboratory through screening a DNA library in a yeast two-hybrid (Y2H), 
using DivIVAEf as bait (Liao et al., manuscript in preparation).  Interaction between DivIVAEf 
and full length MLJD1 was weak in the Y2H potentially due to the heterologous eukaryotic 
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background.  Interaction between DivIVAEf and an MLJD1 fragment including the CBS 
domains was also not very strong in the Y2H, but was stronger than with full length MLJD1 
(Liao et al., manuscript in progress).  Interaction between DivIVAEf and MLJD1 was evident 
with in vitro and in vivo methods such as GST-pulldown and immunoprecipatation respectively 
(Liao et al., manuscript in preparation).  To further confirm that DivIVAEf was interacting with 
MLJD1 I used a more sensitive in vivo Bacteria Two-hybrid (B2H) system (discussed in 
Appendix A) (Di Lallo et al., 2001).  Using bacteria as the background in B2H could eliminate 
any problems seen in the heterologous Y2H system and help detect interactions otherwise 
missed in the Y2H.  Again interaction between DivIVAEf and full length MLJD1 was either not 
detected or very weak.  Because the reciprocal results were contradicting, the weak interaction 
detected in one reciprocal could have been a false positive induced by bridging proteins (Di 
Lallo et al., 2003, Di Lallo et al., 2001).  Unlike divIVAEf expressed from either plasmid alone 
(single plasmid controls) the mljd1 single plasmid controls demonstrated significant 
background repression of β-gal.  Therefore, any repression of β-gal demonstrated between 
DivIVAEf and full length MLJD1 could be due to repression induced by each plasmid’s 
products alone, possibly through bridging proteins as mentioned, rather than a positive 
indication of interaction.  The problem of high background repression of β-gal could also be 
due to the HTH region of MLJD1 potentially binding to DNA, which may cause repression of 
β-gal in the controls.  
 To solve the problem encountered with full length MLJD1, the sequence encoding a 
fragment of MLJD1 containing the CBS domains (a.a. 79-199) were cloned into the B2H 
plasmids.  Without the HTH, the CBS domains should be free to interact directly with 
DivIVAEf.  This hypothesis proved to be correct as there was a strong interaction between 
DivIVAEf and the CBS domain fragment of MLJD1. 
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 After I determined that DivIVAEf interacts with the fragment of MLJD1 containing the 
CBS domains, the next step was to determine which regions of DivIVAEf are involved.  In 
previous Y2H experiments with truncations of DivIVAEf, it was predicted MLJD1 interacted 
with a region of DivIVAEf close to the first central coiled-coil (Liao et al., manuscript in 
progress).  This would be an interesting finding since the central coiled-coils are also involved 
in DivIVAEf oligomerization.  Again the Y2H results were only suggestive.  To test this 
hypothesis of  where DivIVAEf~MLJD1 interaction occurs I tested the interaction capabilities 
between DivIVAEf carrying the MR16L104P, I115P, I125P, L143P mutations with the CBS domain 
containing fragment of MLJD1.  Since the MR16 L104P, I115P, I125P, L143P mutations induce a loss of 
self interaction in DivIVAEf, I hypothesized it would also lose interaction with the CBS domain 
containing fragment.  Preliminary results of one B2H assay studying the interaction of 
DivIVAEf MR16 L104P, I115P, I125P, L143P with the CBS fragment were inconclusive.  Wild type 
DivIVAEf interaction with the CBS fragment was again detected, but when wt DivIVAEf was 
replace by DivIVAEf carrying MR16 L104P, I115P, I125P, L143P the results from the two plasmid 
combinations were conflicting.  These contrasting results could indicate a false negative or a 
false positive, so interaction between the DivIVAEf MR16 L104P, I115P, I125P, L143P mutant and the 
CBS containing fragment of MLJD1 could potentially be stronger or weaker compared to 
interaction with wt DivIVAEf.  The difference between the two combinations could be due to 
differing levels of protein expression caused by the high and low copy plasmids (discussed in 
Appendix A).  GST-pulldown and/or immunoprecipitation with DivIVAEf MR16 L104P, I115P, 
I125P, L143P and the MLJD1 fragment containing the CBS domains could also be used to further 
determine if there is a stronger interaction or a loss of interaction between the two. 
 These results and the results of DivIVAEf and full length MLJD1 indicate the B2H, 
although sensitive enough to prove interaction exists, may not be ideal for determining 
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interaction patterns of these two proteins, possibly due to a dynamic and complex mode of 
interaction.  Recently, a protein in B. subtlils, which contains similar domains to MLJD1 from 
E. faecalis, YqzB (or CcpN) was shown to be involved in carbon catabolite repression (CCR) 
(Servant et al., 2005).  During growth on a preferred carbon source, such as glucose, CcpN 
bindes to the promoters of pckA and gapB, which represses their transcription.  CcpN thereby 
regulates gluconeogenisis (Servant et al., 2005, Tannler et al., 2008).  DivIVAEf and MLJD1 
interaction could depend on the state of DivIVAEf oligomerization and/or growth on different 
carbon sources, which would result in varying levels of ATP and other metabolites.  The 
potential ATP and DNA binding capabilities of MLJD1 could indicate how and when MLJD1 
interacts with DivIVAEf.  Further research on potential ATP and DNA binding capabilities of 
MLJD1 needs to be performed in E. faecalis to further our understanding of the role of MLJD1 
interaction with DivIVAEf and thus in bacterial cell division.  The role of MLJD1 in E. faecalis 
CCR should also be investigated. 
 In summary, the above B2H results indicate a novel interaction between the central 
coiled-coils of DivIVAEf and the CBS domain containing fragment of MLJD1.  These results 
will help devise a model for E. faecalis cell division, which may apply to other Gram-positive 
organisms possessing homologues of DivIVA and MLJD1.  If MLJD1 plays a role in E. 
faecalis CCR as its B. subtilis homologue CcpN does, future research on MLJD1 and CcpN 
could identify a link between carbon metabolism and bacterial cell division. 
4.3 DivIVAEf and MLJD1 Localization in Enterococcus faecalis 
DivIVA in B. subtilis and S. pneumoniae localizes to the cells poles and, at a later stage 
of cell division, the site of cell division (Fadda et al., 2007, Edwards & Errington, 1997).  In 
both instances DivIVA remains at the nascent and new cell poles to help prevent division at 
these sites.  Previous attempts to localize DivIVAEf in E. faecalis using GFP tagged DivIVAEf 
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failed due to the formation of inclusion bodies (Rigden, 2005).  I used immunofluorescence to 
show patterns of DivIVAEf localization in E. faecalis JH2-2.  I also used immunofluorescence 
to determine MLJD1 localization patterns in E. faecalis JH2-2. 
Log phase E. faecalis JH2-2 cells were separated into five stages of cell division based 
on the state of septum formation and constriction, DNA staining of the chromosome, and the 
localization pattern of DivIVAEf or MLJD1, as done for localization patterns of S. pneumoniae 
cell division proteins (Fadda et al., 2007, Lara et al., 2005, Morlot et al., 2003).  For 
localization of DivIVASp in S. pneumoniae six cell division stages were defined.  Fadda et al. 
(2007) found DivIVASp to first localize to the cell poles at Stage 1 of cell division, where there 
is a single cell with a central stained chromosome.  DivIVASp proceeded to localize to the cell 
poles and concurrently as an open ring and then as a closed ring at the center of the S. 
pneumoniae cells, in Stages 2 and 3 respectively (Fadda et al., 2007).  The chromosome at 
Stages 2 and 3 appeared to elongate and then as two chromosomal masses still in close 
proximity, respectively (Fadda et al., 2007).  At Stages 4 and 5, DivIVASp appeared as a band 
or disk at the cell center and remained at the cell poles (Fadda et al., 2007).  At the final stage 
of cell division, Stage 6 for S. pneumoniae, the daughter cells were fully divided but still 
attached.  The cells in Stage 6 of S. pneumoniae appear similar to cells in Stage 3 of cell 
division, the only difference between the two was the diplococci present in Stage 6 instead of 
single cells in Stage 3.  The general findings indcated DivIVASp localized to the old and new 
cell poles in addition to the new division sites of the dividing daughter cells (Fadda et al., 
2007).   
DivIVAEf localization in E. faecalis was similar to that of DivIVASp in S. pneumoniae. 
DivIVAEf localized diffusely around the entire cell membrane during Stage 1 of E. faecalis cell 
division instead of being concentrated at the cell poles as seen for DivIVASp.  DivIVAEf, in 
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Stage 2 and 3 of E. faecalis cell division, localized to form caps at the lancet shaped poles of 
the dividing cells.  The chromosome at Stages 2 and 3 in E. faecalis cell division was similar to 
S. pneumoniae, where it appeared to elongate and then replicate into two chromosomal masses 
still in close proximity, respectively.  However, I did not detect DivIVAEf to form an open or 
closed ring at the division site at these stages as reported for DivIVASp.  At Stage 4 of E. 
faecalis cell division, DivIVAEf localized to the cell poles and at the central division site.  In the 
final stage of E. faecalis cell division, Stage 5 where the cells were completely divided but still 
attached, DivIVAEf localized as it did in Stage 1, diffused across the entire cell membrane.  
 Enterococcus faecalis DivIVAEf localization patterns were similar to S. pneunoniae 
DivIVASp localization patterns, despite differences in cell division stages.  In both cases 
DivIVA localizes to the cell poles and eventually concurrently to the cell division site in 80% 
of S. pneumoniae cells and 17% in E. faecalis cells.  Enterococcus faecalis DivIVAEf appears to 
localize to the cell division site later in cell division (i.e: Stage 4) than DivIVASp in S. 
pneumoniae (i.e: Stage 2 and 3).  DivIVASp also remains at the cell poles after cell division, 
while DivIVAEf tends to be more diffused along the entire cell membrane.  Due to differing 
intensities and levels of background fluorescence as well as no quantitative measures to 
determine stages of cell division, the immunofluorescence localization of DivIVASp and 
DivIVAEf are qualitative.  As mentitioned previously, I could not differentiate DivIVAEf 
localization as a ring, band or disk as the fluorescence was not always that clear (i.e: Stages 2-5 
in S. pneumoniae cell division).  This could be how Fadda et al (2007) was able to identify six 
stages of S. pneumoniae cell division whereas I could only identify five stages of E. faecalis 
cell division.  Fadda et al. (2007) also studied co-localization of DivIVASp with FtsZSp, which 
helped determine when DivIVASp localizes to the cell division site during cell division in 
reference to the development and progression of the divisome.  In B. subtilis DivVIABs was 
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tagged with GFP and found to localize to old and new cell poles and concurrently to the 
division site (Edwards & Errington, 1997).  So, in all three species of Gram-positive bacterium, 
DivVIA localizes to the cell poles and the division site at some point during cell division.   
The novel putative cell division protein MLJD1 appeared to localize in a similar pattern 
as DivIVAEf in E. faecalis, but only at the later stages of cell division.  In Stage 1 and Stage 5 
MLJD1 localized diffusely at the cell membrane as DivIVAEf does.  As cell division progressed 
into Stage 2 and 3, MLJD1 localized along the length of the cell, while DiviVAEf localized to 
the cell poles.  At Stage 4, MLJD1 localized to the cell poles and concurrently to the cell 
division site, just as DivIVAEf had. Since the E. faecalis cells are so small it was difficult to 
definitively define where MLJD1 was localizing, particularly when comparing to DivIVAEf 
localization.  For this reason it would be useful to raise mouse polyclonal primary antibody to 
MLJD1 so co-immunofluorescence can be performed to further identify the localization of 
DivIVAEf and MLJD1. Another issue with comparing DivIVAEf and MLJD1 
immunofluorescence was that the E. faecalis cultures fixed for each, DivIVAEf and MLJD1 
respectively, appeared to be in different stages of cell division.  Co-immunofluorescence 
studies of this nature would help determine if DivIVAEf and MLJD1 localize at the cell poles 
and cell division site during the same time point.  DAPI staining would also be performed to 
investigate the location of the chromosome in conjunction with DivIVAEf and MLJD1 
localization.  Calculating the replication time of the E. faecalis cells would also be useful for 
determining the stage of cell division.  Knowing the replication time under specific growth 
conditions would help define the percentage of cells which are expected to be in the ”C period” 
or “D period” of chromosomal replication and cell division (Haeusser & Levin, 2008).  One 
could even synchronize the culture, so at specific time points the majority of the cells would be 
at similar stages of cell division (Cutler & Evans, 1966).  It would also be interesting to 
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investigate formation of the Z-ring in relation to MLJD1 localization as performed for DivIVA 
in Streptococcus pneumoniae (Fadda et al., 2007).  Improvement of the immunofluorescent 
technique and co-immunofluorescence is being pursued in our laboratory. 
4.4 Proposed Role of MLJD1 in Enterococcus faecalis Cell Division 
Research of DivIVA interaction with other division proteins is a relatively new area of 
study.  In Streptococcus pneumoniae DivIVASp was found to interact with cell division proteins 
FtsZ, FtsA, ZapA, FtsK, FtsL, and PcsB using the B2H assay (Fadda et al., 2007, Di Lallo et 
al., 2001).  Enterococcus faecalis DivIVAEf interacts with FtsA, FtsZ, FtsQ, and FtsW (Laio et 
al., manuscript in progress).  Intriguingly, DivIVASp was also found to interact with Spo0J, 
which is involved in chromosome segregation (Fadda et al., 2007, Ben-Yehuda et al., 2003).  In 
B. subtilis, DivIVABs also interacts indirectly with Spo0J; DivIVABs interacts with RacA, RacA 
interacts with Spo0J, and Spo0J interacts with the origin of replication to aid in positioning the 
chromosome during sporulation (Errington, 2001, Ben-Yehuda et al., 2003).  Now, we have 
determined that DivIVAEf in E. faecalis interacts with a novel division protein, MLJD1, which 
also possesses a potential DNA binding domain.  MLJD1 could thus be a bridge between 
DivIVAEf and the chromosome, aiding in segregation of the daughter chromosomes and 
migration towards opposite poles of the dividing cell. 
In B. subtilis it is known that the interaction between DivIVABs and MinD is vital for 
normal cell division, but direct interaction between DivIVABs and MinD or MinC could not be 
detected.  Two recent studies revealed the finding of a protein, MinJ, which interacts with 
DivIVABs and MinD (Patrick & Kearns, 2008, Bramkamp et al., 2008).  It was proposed that 
MinJ functions as a bridge between DivIVABs and MinD allowing DivIVABs to sequester the 
FtsZ inhibitor MinCD complex to the old and new cell poles of B. subtilis in order to constrict 
cell division to the midcell site (Bramkamp et al., 2008, Patrick & Kearns, 2008).  E. faecalis 
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does not contain MinC, MinD, or MinJ, but we have demonstrated a direct interaction between 
DivIVAEf and the novel putative division protein MLJD1.  As mentioned previously, MLJD1 
could potentially act as a bridge between DivIVAEf and the chromosome much like MinJ acts 
as a bridge between DivIVABs and MinCD complex.  This DivIVAEf~MLJD1~chromosome 
bridge model could explain how DivIVAEf was previously described as essential for E. faecalis 
chromosome segregation (Ramirez-Arcos et al., 2005).  MLJD1 could also be interacting with 
an additional yet undiscovered protein which, along with DivIVAEf, could in turn be 
responsible for midcell positioning of the division site in a similar manner as 
DivIVABs~MinJ~MinCD performs this midcell site selection function.   
MLJD1 in E. faecalis may also play a role in carbon catabolite repression (CCR) as 
does the B. subtilis homologue, CcpN.  The role of CcpN or MLJD1 in cell division and CCR 
may depend on ATP levels and the presence of different metabolites during growth on varying 
carbon sources (Tannler et al., 2008, Servant et al., 2005).  A link between bacterial cell 
division and carbon metabolism could help explain a dynamic mechanism used to control 
growth rates on various carbon sources.  A knockout of ccpN in B. subtilis resulted in a reduced 
growth rate when grown on glucose because pckA and gapB were derepressed (Tannler et al., 
2008, Servant et al., 2005).  Derepression of these gluconeogenic genes caused a deficiency of 
TCA cycle intermediates and ATP levels (Tannler et al., 2008).  Wild type growth rates were 
restored in a ccpN pckA double knockout or supplementation with various TCA cycle 
intermediates (Tannler et al., 2008).  While the B. subtilis ccpN knockout demonstrated a 
decreased growth rate on glucose it showed an increased growth rate when grown on non-sugar 
alternative carbon sources (Servant et al., 2005).  This may indicate CcpN controls the rate of 
B. subtilis cell division when growing on these alternative carbon sources.  A potential role for 
CcpN in bacterial cell division was not reported as there were no reports of the physiological 
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phenotypes of the ccpN knockout.  Our laboratory is currently working on a B. subtilis ccpN 
knockout to identify its chromosome segregation and cell division capabilities.  This research 
will may provide a link between B. subtilis cell division and metabolism and help form future 
experiments to determine the role of MLJD1 in E. faecalis. 
To determine if MLJD1 is forming a bridge between DivIVAEf and the chromosome 
future research on MLJD1 DNA binding capabilities is vital.  Once an association between 
MLJD1 and the chromosome can be made, mutations could be introduced in an attempt to 
disrupt this association to determine if MLJD1 is required for proper chromosome segregation.  
Due to the localization of MLJD1 along the length of E. faecalis cells during early cell division, 
MLJD1 could be acting as a nucleoid occlusion protein to prevent divisome formation and 
closure on replicating chromosomes.  Further research can also be performed to determine if 
MLJD1 is capable of interacting with other known or hither to unknown division proteins and if 
MLJD1 plays a role in E. faecalis CCR. 
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 4.5 Conclusions 
 The current study provides evidence that the N-terminal coiled-coil and oligomerization 
capabilities of DivIVAEf are essential for its biological function in Enterococcus faecalis cell 
division.  I also determined that DivIVAEf localizes to the cell poles and eventually 
concurrently to the site of cell division.  MLJD1 also appeared to localize along the length of E. 
faecalis during the first stages of cell division and eventually to the poles and concurrently to 
the site of cell division.  These initial immunofluorescence experiments of MLJD1 localization 
provided evidence that MLJD1 and DivIVAEf may co-localize during late cell division.  Co-
immunofluorescence of DivIVAEf and MLJD1 in E. faecalis is currently being explored in our 
laboratory to refine our understanding of DivIVAEf and MLJD1 localization. 
Furthermore, I demonstrated the positive interaction between DivIVAEf and a fragment 
of MLJD1 containing two CBS domains using the in vivo Bacterial Two-Hybrid (B2H) system 
(Di Lallo et al., 2001).  However, I was not able to determine the region of DivIVAEf which 
interacts with MLJD1 or detect interaction between DivIVAEf and full length MLJD1 using the 
B2H system.  The interaction between DivIVAEf and MLJD1 could be quite dynamic given 
potential DNA binding, as shown for the B. subtilis homologue CcpN, and ATP binding 
capabilities of MLJD1, which will be investigated in future research. This research on E. 
faecalis DivIVAEf and MLJD1 has set a strong base for future research, so a novel model of cell 
division in Gram-positive cocci can be developed.  Determination of the involvement of 
MLJD1 in gluconeogenesis in E. faecalis and further research in the involvement of CcpN in B. 
subtilis cell division could help elucidate a potential link between bacterial cell metabolism and 
cell division in various Gram-positive organisms. 
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Appendix A 
Bacterial Two-Hybrid Assay: How the System Works and Resolving Complications 
 The Bacterial two-hybrid (B2H) assay is a β-galactosidase (β-gal) assay which is 
utilized to study protein-protein interaction by determining the amount of β-gal produced in 
response to whether two proteins interact or not.  In this system developed by Di Lallo et al. 
(2001), the E. coli R721 reporter strain contains a chimeric operator sequence controlling a lacZ 
gene in the chromosome (Fig A1).  The plasmids used in this B2H system, pcI434 and pcIP22, 
encoded for a fusion protein consisting of the N-terminal of the repressor protein from phage 
434 or phage P22, respectively, with the protein being studied (“x” or “y” in Fig A1) whose 
gene is cloned into the pcI434 and pcIP22 plasmids.  The N-terminal repressor portion recognizes 
and binds to the operator sequence.  The reporter strain was transformed with pcI434 and pcIP22, 
each plasmid carrying the genes of the proteins under study, to test either self-interaction or 
interaction with different proteins.  Reciprocal cloned vectors should also be tested for 
interaction.  If the proteins (s) under study interact they will dimerize causing the N-terminal 
repressors to match the chimeric operator sequence.  In turn the lacZ gene will be repressed 
resulting in a decreased production of β-gal as compared to E. coli R721 background β-gal 
activity when no plasmid is present.  Each B2H plasmids used in the study were also 
transformed seperately into E. coli R721 to check for significant background repression. 
 The B2H assay is not without its complications.  First, the pcI434-linker plasmid is a low 
copy plasmid while the pcIP22-linker plasmid is a high copy plasmid (Di Lallo et al., 2001).  E. 
coli R721 carrying the pcIP22-linker plasmid typically grows slower, or sometimes not at all, 
after being sub-cultured from overnight culture to grow the log phase culture.  For the slow  
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Figure A1:  The Bacterial Two-Hybrid system developed by Di Lallo et al. (2001).  Genes 
encoding proteins of interest, “x” or “y”, are cloned into pcI434 and pcIP22 to 1) create a fusion 
with the N-terminal of the repressor proteins for phages 434 or P22, respectively.  2)  If proteins 
“x” and “y” interact they form a dimmer which 3) binds to the chimeric operator located on the 
E. coli R721 chromosome and thus 4) represses lacZ expression.  Detection of interaction is 
measured by a >50% reduction of β-galactosidase produced as compared to E. coli R721 
containing no plasmids (Di Lallo et al., 2003, Di Lallo et al., 2001, Fadda et al., 2007). 
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 growing cultures a 1:50 dilution was made instead of the 1:100 dilution used by Di Lallo et al. 
(2001).  Some of the slow growing cultures would also be left to grow for 3-3.5 hr instead of 
the 2-2.5 hr for the samples growing at a normal rate, to improve the OD650.  All samples were 
also grown at 34 0C to slow down protein production as to not overwhelm the cells with protein 
and thus ensure cell survival. 
DivIVAEf is known to affect E. coli cell division, creating filamentous cells when over-
expressed (Rigden et al., 2008).  Overexpression of proteins from the high copy plasmids 
pcIP22-linker could thus also affect growth rates of the cultures by impeding cell division in the 
host strain.  The ratio of proteins may have also been affected by the expression from a high or 
low copy plasmid.  Differences between reciprocal results may be due to the protein interaction 
reliability based on a particular ratio of one protein to the other.  A Western blot was performed 
to ascertain DivIVAEf levels in E. coli R721 transformed with pdivIVA434/pdivIVA22 (double 
transformation), pdivIVA434, pdivIVA22, and R721 with no plasmid (Fig A2).  One would 
expect greater DivIVAEf production from E. coli R721 transformed with pdivIVA22, the high 
copy plasmid, as compared to pdivIVA434, the low copy plasmid, upon induction with IPTG.  
However, the opposite was observed (Fig II.2).  The E. coli R721 sample with pdivIVA434 and 
both pdivIVA434 and pdivIVA22 showed increased DivIVAEf production when induced with 
IPTG, whereas the sample with pdivIVA22 alone did not produce more DivIVAEf (Fig II.2).  
Because pdivIVA22 is a high copy plasmid DivIVAEf (fused to N-terminal of phage P22) may 
be produced in high enough quantities to form inclusion bodies.  The inclusion bodies would 
not be soluble and therefore the P22 N-terminal-DivIVAEf fusion protein would not be detected 
in the Western blot.  To check for inclusion bodies I would sonicate E. coli R721 carrying 
pdivIVA22 and centrifuge at 25000 rpm to collect insoluble fractions.  I would keep a sample 
of the supernatant to check it for protein.     
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Figure A2: Western blot of E. coli R721 transformed with indicated B2H plasmids.  The 
samples were grown to exponential phase by following the same method used for performing a 
bacterial two-hybrid β-galactosidase assay (see section 2.5).  The experiment was repeated 
once.  
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I would then add 8M urea to the collected pellet to suspend potential inclusion bodies.  I would 
do a Western blot of the supernatant sample and the inclusion body sample to compare.  
Inclusion bodies could also explain why E. coli R721 carrying pcIP22 or its derivatives did not 
typically grow well.  Also note that DivIVAEf, predicted to have a molecular weight of 27 kDa 
appears to have a higher molecular weight after SDS-PAGE electrophoresis.  This aberration in 
DivIVAEf migration is most likely due to the charge of DivIVAEf  as described in Rigden et al. 
(Rigden et al., 2008). 
 To obtain reproducible results with repeated B2H assays it was important to use the 
same Z-buffer and prepare fresh assay reagents.  The same stock of IPTG was also used for 
repeated experiments to reduce small variations of concentration.  Due to damage of freeze-
thawing of stock E. coli R721 it is also important to re-transform the B2H plasmids if the assay, 
which was previously working, starts yielding inconsistent results.  
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